TWI797021B - Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition, liquid crystal display device - Google Patents

Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition, liquid crystal display device Download PDF

Info

Publication number
TWI797021B
TWI797021B TW111121360A TW111121360A TWI797021B TW I797021 B TWI797021 B TW I797021B TW 111121360 A TW111121360 A TW 111121360A TW 111121360 A TW111121360 A TW 111121360A TW I797021 B TWI797021 B TW I797021B
Authority
TW
Taiwan
Prior art keywords
liquid crystal
mmol
negative dielectric
dielectric anisotropy
straight
Prior art date
Application number
TW111121360A
Other languages
Chinese (zh)
Other versions
TW202309252A (en
Inventor
舒克倫
張孟勛
劉永祥
黃曼萍
尹碩
賴育宏
豐佩川
Original Assignee
大陸商煙台顯華科技集團股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商煙台顯華科技集團股份有限公司 filed Critical 大陸商煙台顯華科技集團股份有限公司
Publication of TW202309252A publication Critical patent/TW202309252A/en
Application granted granted Critical
Publication of TWI797021B publication Critical patent/TWI797021B/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3491Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having sulfur as hetero atom
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal (AREA)

Abstract

本發明涉及具有負介電各向異性的液晶化合物、液晶組合物、液晶顯示器件。所述液晶化合物在維持一定水平的負型介電常數的基礎上具有小的響應指標值從而具有更快的響應時間。The invention relates to a liquid crystal compound, a liquid crystal composition and a liquid crystal display device with negative dielectric anisotropy. The liquid crystal compound has a small response index value on the basis of maintaining a certain level of negative dielectric constant and thus has a faster response time.

Description

具有負介電各向異性的液晶化合物、液晶組合物、液晶顯示器件Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition, liquid crystal display device

本發明涉及液晶顯示材料領域,具體涉及具有負介電各向異性的液晶化合物、液晶組合物及液晶顯示器件。The invention relates to the field of liquid crystal display materials, in particular to a liquid crystal compound with negative dielectric anisotropy, a liquid crystal composition and a liquid crystal display device.

目前,液晶化合物的應用範圍拓展的越來越廣,其可應用於多種類型的顯示器、電光器件、傳感器等中。用於上述顯示領域的液晶化合物的種類繁多,其中向列相液晶應用最為廣泛。向列相液晶已經應用在無源TN、STN矩陣顯示器和具有TFT有源矩陣的系統中。At present, the application range of liquid crystal compounds is expanding more and more widely, and it can be applied to various types of displays, electro-optic devices, sensors, and the like. There are various types of liquid crystal compounds used in the above-mentioned display fields, among which nematic liquid crystals are most widely used. Nematic liquid crystals have been used in passive TN, STN matrix displays and systems with TFT active matrix.

對於薄膜晶體管技術(TFT-LCD)應用領域,近年來市場雖然已經非常巨大,技術也逐漸成熟,但人們對顯示技術的要求也在不斷的提高。隨著TFT-LCD的不斷發展,寬視角模式已成為行業內追求的目標,目前主流的寬視角技術主要採用VA垂直取向、IPS面內開關及FFS邊緣場開關等顯示類型。這些顯示模式,廣泛採用具有負介電各向異性的液晶介質。For the application field of thin film transistor technology (TFT-LCD), although the market has been huge and the technology has gradually matured in recent years, people's requirements for display technology are also constantly improving. With the continuous development of TFT-LCD, the wide viewing angle mode has become the goal pursued by the industry. At present, the mainstream wide viewing angle technology mainly adopts display types such as VA vertical orientation, IPS in-plane switching and FFS fringe field switching. For these display modes, liquid crystal media with negative dielectric anisotropy are widely used.

對於用於這些模式的液晶介質,對其響應時間的要求越來越高。而液晶介質的響應時間受到清亮點T NI(℃)、折光率(Δn)、介電常數(

Figure 02_image003
)、彈性係數(Kii、pN)、旋轉粘度(Gamma 1, mPa.s)等多個因素的影響,如何獲得這些因素綜合作用下的響應時間提高的液晶化合物是本領域亟待解決的問題之一。 The demands on the response time of the liquid-crystalline media used in these modes are increasingly higher. The response time of the liquid crystal medium is affected by the clearing point T NI (℃), the refractive index (Δn), the dielectric constant (
Figure 02_image003
), elastic coefficient (Kii, pN), rotational viscosity (Gamma 1, mPa.s) and other factors, how to obtain the liquid crystal compound whose response time is improved under the combined effect of these factors is one of the problems to be solved urgently in this field .

本發明針對上述現有技術存在的問題,進行了深入的研究後發現,採用本發明的式I所示的液晶化合物,能夠獲得在維持一定水平的負型介電常數的基礎上具有提高的響應時間的新型液晶化合物,由此完成了本發明。The present invention aims at the problems existing in the above-mentioned prior art. After in-depth research, it is found that the liquid crystal compound shown in the formula I of the present invention can obtain a response time that is improved on the basis of maintaining a certain level of negative dielectric constant. novel liquid crystal compounds, thus completing the present invention.

對於液晶介質,根據顯示模式的不同,液晶介質的響應時間與G1/(K 11*△n*△n)或者G1/(K 33*△n*△n)相關。具體地,在VA(vertical alignment,垂直取向)或者PS-VA(Polymer stabilized vertical alignment,聚合物穩定垂直取向)模式下,液晶介質的響應時間與G1/(K 33*△n*△n)的值相關,而在FFS(Fringe Field Switching,邊緣場開關)、IPS(In-Plane Switching,平面轉換)、PS-FFS(Polymer stabilized Fringe Field Switching,聚合物穩定邊緣場開關)、PS-IPS(Polymer stabilized In-Plane Switching,聚合物穩定平面轉換)等模式下,液晶介質的響應時間與G1/(K 11*△n*△n)的值相關。 For liquid crystal media, according to different display modes, the response time of liquid crystal media is related to G1/(K 11 *△n*△n) or G1/(K 33 *△n*△n). Specifically, in VA (vertical alignment, vertical alignment) or PS-VA (Polymer stabilized vertical alignment, polymer stabilized vertical alignment) mode, the response time of the liquid crystal medium is related to that of G1/(K 33 *△n*△n) Value-related, while in FFS (Fringe Field Switching, fringe field switch), IPS (In-Plane Switching, plane conversion), PS-FFS (Polymer stabilized Fringe Field Switching, polymer stabilized fringe field switch), PS-IPS (Polymer Stabilized In-Plane Switching, polymer stabilized plane switching) and other modes, the response time of the liquid crystal medium is related to the value of G1/(K 11 *△n*△n).

在本申請中,將G1/(K 33*△n*△n)、G1/(K 11*△n*△n)的值稱為響應指標值。前述響應指標值越小,表明液晶介質的響應時間越快。 In the present application, the values of G1/(K 33 *Δn*Δn) and G1/(K 11 *Δn*Δn) are referred to as response index values. The smaller the aforementioned response index value, the faster the response time of the liquid crystal medium.

本發明的具有負介電各向異性的液晶化合物在維持一定水平的負型介電常數的基礎上具有小的響應指標值從而具有提高的響應時間。The liquid crystal compound with negative dielectric anisotropy of the present invention has a small response index value and thus an improved response time on the basis of maintaining a certain level of negative dielectric constant.

本發明包括下述的技術方案:The present invention comprises following technical scheme:

一方面,本發明提供一種具有負介電各向異性的液晶化合物,所述化合物具有下述的式Ⅰ所示的結構:

Figure 02_image005
Ⅰ In one aspect, the present invention provides a liquid crystal compound with negative dielectric anisotropy, the compound has the structure shown in the following formula I:
Figure 02_image005
I

式I中,R 1、R 2各自獨立地表示氫原子、碳原子數為1~8的直鏈烷基、碳原子數為1~8的直鏈烷氧基、碳原子數為2~8的直鏈烯基、碳原子數為2~8的直鏈烯氧基,其中一個或兩個不相鄰的-CH 2-任選被-O-取代,任意H任選被F原子取代; In formula I, R 1 and R 2 each independently represent a hydrogen atom, a straight-chain alkyl group with 1 to 8 carbon atoms, a straight-chain alkoxy group with 1 to 8 carbon atoms, and a straight chain alkoxy group with 2 to 8 carbon atoms. straight-chain alkenyl, straight-chain alkenyloxy with 2 to 8 carbon atoms, in which one or two non-adjacent -CH 2 -s are optionally substituted by -O-, and any H is optionally substituted by an F atom;

環A1選自下述的基團組成的組:1,4-亞環己基、環己烯-1,4-二基、1,4-亞苯基、2-氟-1,4-亞苯基、2,3-二氟-1,4-亞苯基、氧雜環己烷-2,5-二基、1,3-二氧雜環己烷-2,5-二基、1-甲基環己烷-1,4-二基、2-甲基環己烷-1,4-二基、2-甲基苯-1,4-二基;Ring A1 is selected from the group consisting of 1,4-cyclohexylene, cyclohexene-1,4-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene base, 2,3-difluoro-1,4-phenylene, oxane-2,5-diyl, 1,3-dioxane-2,5-diyl, 1- Methylcyclohexane-1,4-diyl, 2-methylcyclohexane-1,4-diyl, 2-methylbenzene-1,4-diyl;

Z表示單鍵、-C 2H 2-、-C 2H 4-、-C 2H 2CH 2O-、-OCH 2C 2H 2-、-CH 2O-、-OCH 2-、-C 2H 2CH 2S-、-SCH 2C 2H 2-、-CH 2S-、-SCH 2-、-O-、-S-、-CF 2O-、-OCF 2-、-C≡C-、-OOC-、或者-COO-,其中-CH 2O-、-C 2H 2-、-C 2H 4-、-C 2H 2CH 2O-、-OCH 2C 2H 2-中的任意H任選被F取代; Z represents a single bond, -C 2 H 2 -, -C 2 H 4 -, -C 2 H 2 CH 2 O-, -OCH 2 C 2 H 2 -, -CH 2 O-, -OCH 2 -, - C 2 H 2 CH 2 S-, -SCH 2 C 2 H 2 -, -CH 2 S-, -SCH 2 -, -O-, -S-, -CF 2 O-, -OCF 2 -, -C ≡C-, -OOC-, or -COO-, where -CH 2 O-, -C 2 H 2 -, -C 2 H 4 -, -C 2 H 2 CH 2 O-, -OCH 2 C 2 H Any H in 2- is optionally substituted by F;

X表示-O-、-S-、-SO-、-SOO-、-CF 2-、-CO-或者-CH 2-; X represents -O-, -S-, -SO-, -SOO-, -CF 2 -, -CO- or -CH 2 -;

Y 1、Y 2各自獨立地表示-F-、-CH 2F-、-CHF 2-、-CF 3-、-OCH 2F-、-OCHF 2-或者-OCF 3-; Y 1 and Y 2 each independently represent -F-, -CH 2 F-, -CHF 2 -, -CF 3 -, -OCH 2 F-, -OCHF 2- or -OCF 3 -;

n表示0、1、2或者3。n represents 0, 1, 2 or 3.

本發明另一方面提供一種液晶組合物,其含有前述的本發明的具有負介電各向異性的液晶化合物。Another aspect of the present invention provides a liquid crystal composition, which contains the aforementioned liquid crystal compound with negative dielectric anisotropy of the present invention.

本發明的又一方面提供一種液晶顯示器件,其含有前述的本發明的具有負介電各向異性的液晶化合物或者前述的本發明的液晶組合物。Still another aspect of the present invention provides a liquid crystal display device, which contains the aforementioned liquid crystal compound with negative dielectric anisotropy of the present invention or the aforementioned liquid crystal composition of the present invention.

發明效果Invention effect

與現有技術相比,本發明的具有負介電各向異性的液晶化合物在維持一定水平的負型介電常數的基礎上具有小的響應指標值從而具有更快的響應時間。通過在本發明的液晶組合物中使用本發明的具有負介電各向異性的液晶化合物,在本發明的液晶顯示器件中含有使用了本發明的液晶化合物的液晶組合物,能夠使得顯示裝置的響應時間更快。Compared with the prior art, the liquid crystal compound with negative dielectric anisotropy of the present invention has a small response index value on the basis of maintaining a certain level of negative dielectric constant and thus has a faster response time. By using the liquid crystal compound with negative dielectric anisotropy of the present invention in the liquid crystal composition of the present invention, and containing the liquid crystal composition using the liquid crystal compound of the present invention in the liquid crystal display device of the present invention, the display device can be made Response time is faster.

以下將結合具體實施方案來說明本發明。需要說明的是,下面的實施例為本發明的示例,僅用來說明本發明,而不用來限制本發明。在不偏離本發明主旨或範圍的情況下,可進行本發明構思內的其他組合和各種改良。The present invention will be described below in combination with specific embodiments. It should be noted that the following examples are examples of the present invention, and are only used to illustrate the present invention, not to limit the present invention. Other combinations and various modifications within the concept of the present invention can be made without departing from the spirit or scope of the present invention.

[具有負介電各向異性的液晶化合物][Liquid Crystal Compounds with Negative Dielectric Anisotropy]

本發明的具有負介電各向異性的液晶化合物具有下述的式Ⅰ所示的結構:

Figure 02_image005
Ⅰ The liquid crystal compound with negative dielectric anisotropy of the present invention has the structure shown in the following formula I:
Figure 02_image005
I

式I中,R 1、R 2各自獨立地表示氫原子、碳原子數為1~8的直鏈烷基、碳原子數為1~8的直鏈烷氧基、碳原子數為2~8的直鏈烯基、或者碳原子數為2~8的直鏈烯氧基,其中一個或兩個不相鄰的-CH 2-任選被-O-取代,任意H任選被F原子取代。 In formula I, R 1 and R 2 each independently represent a hydrogen atom, a straight-chain alkyl group with 1 to 8 carbon atoms, a straight-chain alkoxy group with 1 to 8 carbon atoms, and a straight chain alkoxy group with 2 to 8 carbon atoms. straight-chain alkenyl, or straight-chain alkenyloxy with 2 to 8 carbon atoms, in which one or two non-adjacent -CH 2 -s are optionally substituted by -O-, and any H is optionally substituted by an F atom .

環A1選自下述的基團組成的組:1,4-亞環己基、環己烯-1,4-二基、1,4-亞苯基、2-氟-1,4-亞苯基、2,3-二氟-1,4-亞苯基、氧雜環己烷-2,5-二基、1,3-二氧雜環己烷-2,5-二基、1-甲基環己烷-1,4-二基、2-甲基環己烷-1,4-二基、2-甲基苯-1,4-二基。Ring A1 is selected from the group consisting of 1,4-cyclohexylene, cyclohexene-1,4-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene base, 2,3-difluoro-1,4-phenylene, oxane-2,5-diyl, 1,3-dioxane-2,5-diyl, 1- Methylcyclohexane-1,4-diyl, 2-methylcyclohexane-1,4-diyl, 2-methylbenzene-1,4-diyl.

前述的2-氟-1,4-亞苯基表示下述的2個二價基團,其中的氟取代基可以位於左側,也可以位於右側。其他類似的基團也適用該規則。

Figure 02_image008
Figure 02_image010
The aforementioned 2-fluoro-1,4-phenylene represents the following two divalent groups, in which the fluorine substituent may be on the left side or on the right side. This rule also applies to other similar groups.
Figure 02_image008
,
Figure 02_image010

Z表示單鍵、-C 2H 2-、-C 2H 4-、-C 2H 2CH 2O-、-OCH 2C 2H 2-、-CH 2O-、-OCH 2-、-C 2H 2CH 2S-、-SCH 2C 2H 2-、-CH 2S-、-SCH 2-、-O-、-S-、-CF 2O-、-OCF 2-、-C≡C-、-OOC-或者-COO-,其中-CH 2O-、-C 2H 2-、-C 2H 4-、-C 2H 2CH 2O-、-OCH 2C 2H 2-中任意H任選被F取代; Z represents a single bond, -C 2 H 2 -, -C 2 H 4 -, -C 2 H 2 CH 2 O-, -OCH 2 C 2 H 2 -, -CH 2 O-, -OCH 2 -, - C 2 H 2 CH 2 S-, -SCH 2 C 2 H 2 -, -CH 2 S-, -SCH 2 -, -O-, -S-, -CF 2 O-, -OCF 2 -, -C ≡C-, -OOC- or -COO-, where -CH 2 O-, -C 2 H 2 -, -C 2 H 4 -, -C 2 H 2 CH 2 O-, -OCH 2 C 2 H 2 Any H in - is optionally replaced by F;

X表示-O-、-S-、-SO-、-SOO-、-CF 2-、-CO-或者-CH 2-; X represents -O-, -S-, -SO-, -SOO-, -CF 2 -, -CO- or -CH 2 -;

Y 1、Y 2各自獨立地表示-F-、-CH 2F-、-CHF 2-、-CF 3-、-OCH 2F-、-OCHF 2-或者-OCF 3-; Y 1 and Y 2 each independently represent -F-, -CH 2 F-, -CHF 2 -, -CF 3 -, -OCH 2 F-, -OCHF 2- or -OCF 3 -;

n表示0、1、2或3。n represents 0, 1, 2 or 3.

作為前述的“碳原子數為1~8的直鏈烷基”,可以列舉出例如,甲基、乙基、正丙基、正丁基、正戊基、正己基、正庚基、正辛基等。Examples of the aforementioned "straight-chain alkyl group having 1 to 8 carbon atoms" include methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl Base etc.

作為前述的“碳原子數為1~8的直鏈烷氧基”,可以列舉出例如,甲氧基、乙氧基、正丙氧基、正丁氧基、正戊氧基、正己氧基、正庚氧基、正辛氧基等。Examples of the aforementioned "straight-chain alkoxy group having 1 to 8 carbon atoms" include methoxy, ethoxy, n-propoxy, n-butoxy, n-pentyloxy, and n-hexyloxy. , n-heptyloxy, n-octyloxy, etc.

作為前述的“碳原子數為2~8的直鏈烯基”,可以列舉出例如,乙烯基、1-丙烯基、2-丙烯基、1-丁烯基、2-丁烯基、3-丁烯基、1-戊烯基、2-戊烯基、1-己烯基、2-己烯基、3-己烯基、1-庚烯基、2-庚烯基、3-庚烯基、1-辛烯基、2-辛烯基、3-辛烯基。Examples of the aforementioned "straight-chain alkenyl group having 2 to 8 carbon atoms" include vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, Butenyl, 1-pentenyl, 2-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 1-heptenyl, 2-heptenyl, 3-heptenyl 1-octenyl, 2-octenyl, 3-octenyl.

作為前述的“碳原子數為2~8的直鏈烯氧基”,可以列舉出例如,乙烯氧基、1-丙烯氧基、2-丙烯氧基、1-丁烯氧基、2-丁烯氧基、3-丁烯氧基、1-戊烯氧基、2-戊烯氧基、1-己烯氧基、2-己烯氧基、3-己烯氧基、1-庚烯氧基、2-庚烯氧基、3-庚烯氧基、1-辛烯氧基、2-辛烯氧基、3-辛烯氧基等。Examples of the aforementioned "straight-chain alkenyloxy group having 2 to 8 carbon atoms" include ethyleneoxy, 1-propyleneoxy, 2-propyleneoxy, 1-butenyloxy, 2-but Alkenyloxy, 3-butenyloxy, 1-pentenyloxy, 2-pentenyloxy, 1-hexenyloxy, 2-hexenyloxy, 3-hexenyloxy, 1-heptene oxy, 2-heptenyloxy, 3-heptenyloxy, 1-octenyloxy, 2-octenyloxy, 3-octenyloxy and the like.

前述的“一個或兩個不相鄰的-CH 2-任選被-O-取代”是指,前述的碳原子數為1~8的直鏈烷基、碳原子數為1~8的直鏈烷氧基、碳原子數為2~8的直鏈烯基、碳原子數為2~8的直鏈烯氧基中的任意-CH 2-任選被取代為-O-,但是相鄰的-CH 2-不會同時被取代。 The aforementioned "one or two non-adjacent -CH 2 - optionally substituted by -O-" means that the aforementioned straight-chain alkyl group with 1-8 carbon atoms, straight-chain alkyl group with 1-8 carbon atoms Any -CH 2 - in alkoxy, straight-chain alkenyl with 2 to 8 carbon atoms, and straight-chain alkenyloxy with 2 to 8 carbon atoms is optionally substituted with -O-, but the adjacent The -CH 2 - is not simultaneously substituted.

前述的“任意H任選被F原子取代”,是指,對於F取代的個數沒有任何的限定,可以為單氟取代、多氟取代、或者全氟取代。The aforementioned "any H is optionally substituted by an F atom" means that there is no limitation on the number of F substitutions, which may be monofluoro, polyfluoro, or perfluoro substituted.

優選地,前述R 1表示氫原子、碳原子數1~5的直鏈烷基、碳原子數1~5的直鏈烷氧基、碳原子數2~5的直鏈烯基、或者、碳原子數2~5的直鏈烯氧基,其中一個或兩個不相鄰的-CH 2-任選被-O-取代,任意H任選被F原子取代。 Preferably, the aforementioned R represents a hydrogen atom, a straight-chain alkyl group with 1 to 5 carbon atoms, a straight-chain alkoxy group with 1 to 5 carbon atoms, a straight-chain alkenyl group with 2 to 5 carbon atoms, or carbon A linear alkenyloxy group with 2 to 5 atoms, in which one or two non-adjacent -CH 2 -s are optionally substituted by -O-, and any H is optionally substituted by an F atom.

前述的“碳原子數1~5的直鏈烷基”,可以列舉出例如,甲基、乙基、正丙基、正丁基、正戊基等。優選為甲基、乙基或者正丙基。The aforementioned "straight-chain alkyl group having 1 to 5 carbon atoms" includes, for example, methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group and the like. Preferred is methyl, ethyl or n-propyl.

作為前述的“碳原子數1~5的直鏈烷氧基”,可以列舉出例如,甲氧基、乙氧基、正丙氧基、正丁氧基、正戊氧基。優選為甲氧基、乙氧基或者正丙氧基。Examples of the "straight-chain alkoxy group having 1 to 5 carbon atoms" include methoxy, ethoxy, n-propoxy, n-butoxy, and n-pentoxy. Preference is given to methoxy, ethoxy or n-propoxy.

作為前述的“碳原子數2~5的直鏈烯基”,可以列舉出例如,乙烯基、1-丙烯基、2-丙烯基、1-丁烯基、2-丁烯基、3-丁烯基、1-戊烯基、2-戊烯基、3-戊烯基。優選為乙烯基、1-丙烯基、3-丁烯基、或者、3-戊烯基。Examples of the aforementioned "straight-chain alkenyl group having 2 to 5 carbon atoms" include vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl Alkenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl. Preferred is vinyl, 1-propenyl, 3-butenyl, or 3-pentenyl.

作為前述的“碳原子數2~5的直鏈烯氧基”,可以列舉出例如,乙烯氧基、1-丙烯氧基、2-丙烯氧基、1-丁烯氧基、2-丁烯氧基、3-丁烯氧基、1-戊烯氧基、2-戊烯氧基、3-戊烯氧基。優選為乙烯氧基、1-丙烯氧基、3-丁烯氧基、或者、3-戊烯氧基。Examples of the aforementioned "straight-chain alkenyloxy group having 2 to 5 carbon atoms" include ethyleneoxy, 1-propyleneoxy, 2-propyleneoxy, 1-buteneoxy, 2-butene Oxy, 3-butenyloxy, 1-pentenyloxy, 2-pentenyloxy, 3-pentenyloxy. Preferably, it is ethyleneoxy, 1-propyleneoxy, 3-butenyloxy, or 3-pentenyloxy.

前述的碳原子數1~5的直鏈烷基、碳原子數1~5的直鏈烷氧基、碳原子數2~5的直鏈烯基、或者、碳原子數2~5的直鏈烯氧基中,一個或兩個不相鄰的-CH 2-任選被-O-取代,任意H任選被F原子取代。 The aforementioned straight-chain alkyl group with 1 to 5 carbon atoms, straight-chain alkoxy group with 1-5 carbon atoms, straight-chain alkenyl group with 2-5 carbon atoms, or straight-chain group with 2-5 carbon atoms In alkenyloxy, one or two non-adjacent -CH 2 -s are optionally substituted by -O-, and any H is optionally substituted by F atoms.

本發明的式I所示的化合物的一些實施方式中,前述的R 1優選為碳原子數1~5的直鏈烷基或者碳原子數2~5的直鏈烯基。 In some embodiments of the compound represented by formula I of the present invention, the aforementioned R 1 is preferably a straight-chain alkyl group with 1 to 5 carbon atoms or a straight-chain alkenyl group with 2 to 5 carbon atoms.

本發明的式I所示的化合物的一些實施方式中,前述的R 2優選為碳原子數1~5的直鏈烷氧基或者碳原子數2~5的直鏈烯氧基。 In some embodiments of the compound represented by formula I of the present invention, the aforementioned R2 is preferably a straight-chain alkoxy group with 1 to 5 carbon atoms or a straight-chain alkenyloxy group with 2 to 5 carbon atoms.

本發明的式I所示的化合物的一些實施方式中,環A1優選為1,4-亞環己基、環己烯-1,4-二基或者1,4-亞苯基,更優選為1,4-亞環己基。In some embodiments of the compound represented by formula I of the present invention, ring A1 is preferably 1,4-cyclohexylene, cyclohexene-1,4-diyl or 1,4-phenylene, more preferably 1 ,4-cyclohexylene.

本發明的式I所示的化合物的一些實施方式中,Z優選表示單鍵、-C 2H 2-、或者-C 2H 4-,更優選為單鍵。 In some embodiments of the compound represented by formula I of the present invention, Z preferably represents a single bond, -C 2 H 2 -, or -C 2 H 4 -, more preferably a single bond.

本發明的式I所示的化合物的一些實施方式中,X優選為-O-或者-S-。In some embodiments of the compound represented by formula I of the present invention, X is preferably -O- or -S-.

式I中,n表示0、1、2、或者3,從獲得更小的響應指標值從而具有更快的響應時間等方面考慮,n優選為0、1或者2,進一步優選為n=0或者1。In formula I, n represents 0, 1, 2, or 3, and from aspects such as obtaining a smaller response index value and thus having a faster response time, n is preferably 0, 1 or 2, and is more preferably n=0 or 1.

本發明的具有負介電各向異性的液晶化合物中,優選地,其選自下述的式IA~IN、Ia-In所示化合物組成。

Figure 02_image012
IA
Figure 02_image014
IB
Figure 02_image016
IC
Figure 02_image018
ID
Figure 02_image020
IE
Figure 02_image022
IF
Figure 02_image024
IG
Figure 02_image026
IH
Figure 02_image028
II
Figure 02_image030
IJ
Figure 02_image032
IK
Figure 02_image034
IL
Figure 02_image036
IM
Figure 02_image038
IN
Figure 02_image040
Ia
Figure 02_image042
Ib
Figure 02_image044
Ic
Figure 02_image046
Id
Figure 02_image048
Ie
Figure 02_image050
If
Figure 02_image052
Ig
Figure 02_image054
Ih
Figure 02_image056
Ii
Figure 02_image058
Ij
Figure 02_image060
Ik
Figure 02_image062
Il
Figure 02_image064
Im
Figure 02_image066
In Among the liquid crystal compounds with negative dielectric anisotropy of the present invention, preferably, they are selected from the compounds represented by the following formulas IA-IN and Ia-In.
Figure 02_image012
IA
Figure 02_image014
IB
Figure 02_image016
IC
Figure 02_image018
ID
Figure 02_image020
IE
Figure 02_image022
IF
Figure 02_image024
IG
Figure 02_image026
IH
Figure 02_image028
II
Figure 02_image030
IJ
Figure 02_image032
IK
Figure 02_image034
IL
Figure 02_image036
IM
Figure 02_image038
IN
Figure 02_image040
Ia
Figure 02_image042
Ib
Figure 02_image044
IC
Figure 02_image046
ID
Figure 02_image048
Ie
Figure 02_image050
If
Figure 02_image052
Ig
Figure 02_image054
Ih
Figure 02_image056
II
Figure 02_image058
Ij
Figure 02_image060
Ik
Figure 02_image062
Il
Figure 02_image064
Im
Figure 02_image066
In

其中,R 1、R 2的定義與前述相同。 Wherein, the definitions of R 1 and R 2 are the same as above.

進一步,本發明的具有負介電各向異性的液晶化合物優選為選自下述的式IA-1~IN-4、Ia-1~In-4所示的化合物組成的組,其中,Alkyl各自獨立地表示碳原子數為1~8的直鏈烷基、Alkenyl各自獨立地表示碳原子數為2~8的直鏈烯基,

Figure 02_image068
IA-1
Figure 02_image070
IA-2
Figure 02_image072
IA-3
Figure 02_image074
IA-4
Figure 02_image076
IB-1
Figure 02_image078
IB-2
Figure 02_image080
IB-3
Figure 02_image082
IB-4
Figure 02_image084
IC-1
Figure 02_image086
IC-2
Figure 02_image088
IC-3
Figure 02_image090
IC-4
Figure 02_image092
ID-1
Figure 02_image094
ID-2
Figure 02_image096
ID-3
Figure 02_image098
ID-4
Figure 02_image100
IE-1
Figure 02_image102
IE-2
Figure 02_image104
IE-3
Figure 02_image106
IE-4
Figure 02_image108
IF-1
Figure 02_image110
IF-2
Figure 02_image112
IF-3
Figure 02_image114
IF-4
Figure 02_image116
IG-1
Figure 02_image118
IG-2
Figure 02_image120
IG-3
Figure 02_image122
IG-4
Figure 02_image124
IH-1
Figure 02_image126
IH-2
Figure 02_image128
IH-3
Figure 02_image130
IH-4
Figure 02_image132
II-1
Figure 02_image134
II-2
Figure 02_image136
II-3
Figure 02_image138
II-4
Figure 02_image140
IJ-1
Figure 02_image142
IJ-2
Figure 02_image144
IJ-3
Figure 02_image146
IJ-4
Figure 02_image148
IK-1
Figure 02_image150
IK-2
Figure 02_image152
IK-3
Figure 02_image154
IK-4
Figure 02_image156
IL-1
Figure 02_image158
IL-2
Figure 02_image160
IL-3
Figure 02_image162
IL-4
Figure 02_image164
IM-1
Figure 02_image166
IM-2
Figure 02_image168
IM-3
Figure 02_image170
IM-4
Figure 02_image172
IN-1
Figure 02_image174
IN-2
Figure 02_image176
IN-3
Figure 02_image178
IN-4
Figure 02_image180
Ia-1
Figure 02_image182
Ia-2
Figure 02_image184
Ia-3
Figure 02_image186
Ia-4
Figure 02_image188
Ib-1
Figure 02_image190
Ib-2
Figure 02_image192
Ib-3
Figure 02_image194
Ib-4
Figure 02_image196
Ic-1
Figure 02_image198
Ic-2
Figure 02_image200
Ic-3
Figure 02_image202
Ic-4
Figure 02_image204
Id-1
Figure 02_image206
Id-2
Figure 02_image208
Id-3
Figure 02_image210
Id-4
Figure 02_image212
Ie-1
Figure 02_image214
Ie-2
Figure 02_image216
Ie-3
Figure 02_image218
Ie-4
Figure 02_image220
If-1
Figure 02_image222
If-2
Figure 02_image224
If-3
Figure 02_image226
If-4
Figure 02_image228
Ig-1
Figure 02_image230
Ig-2
Figure 02_image232
Ig-3
Figure 02_image234
Ig-4
Figure 02_image236
Ih-1
Figure 02_image238
Ih-2
Figure 02_image240
Ih-3
Figure 02_image242
Ih-4
Figure 02_image244
Ii-1
Figure 02_image246
Ii-2
Figure 02_image248
Ii-3
Figure 02_image250
Ii-4
Figure 02_image252
Ij-1
Figure 02_image254
Ij-2
Figure 02_image256
Ij-3
Figure 02_image258
Ij-4
Figure 02_image260
Ik-1
Figure 02_image262
Ik-2
Figure 02_image264
Ik-3
Figure 02_image266
Ik-4
Figure 02_image268
Il-1
Figure 02_image270
Il-2
Figure 02_image272
Il-3
Figure 02_image274
Il-4
Figure 02_image276
Im-1
Figure 02_image278
Im-2
Figure 02_image280
Im-3
Figure 02_image282
Im-4
Figure 02_image284
In-1
Figure 02_image286
In-2
Figure 02_image288
In-3
Figure 02_image290
In-4 Further, the liquid crystal compound with negative dielectric anisotropy of the present invention is preferably selected from the group consisting of compounds represented by the following formulas IA-1~IN-4, Ia-1~In-4, wherein each of Alkyl independently represent a straight-chain alkyl group with 1 to 8 carbon atoms, and Alkenyl each independently represent a straight-chain alkenyl group with a carbon number of 2 to 8,
Figure 02_image068
IA-1
Figure 02_image070
IA-2
Figure 02_image072
IA-3
Figure 02_image074
IA-4
Figure 02_image076
IB-1
Figure 02_image078
IB-2
Figure 02_image080
IB-3
Figure 02_image082
IB-4
Figure 02_image084
IC-1
Figure 02_image086
IC-2
Figure 02_image088
IC-3
Figure 02_image090
IC-4
Figure 02_image092
ID-1
Figure 02_image094
ID-2
Figure 02_image096
ID-3
Figure 02_image098
ID-4
Figure 02_image100
IE-1
Figure 02_image102
IE-2
Figure 02_image104
IE-3
Figure 02_image106
IE-4
Figure 02_image108
IF-1
Figure 02_image110
IF-2
Figure 02_image112
IF-3
Figure 02_image114
IF-4
Figure 02_image116
IG-1
Figure 02_image118
IG-2
Figure 02_image120
IG-3
Figure 02_image122
IG-4
Figure 02_image124
IH-1
Figure 02_image126
IH-2
Figure 02_image128
IH-3
Figure 02_image130
IH-4
Figure 02_image132
II-1
Figure 02_image134
II-2
Figure 02_image136
II-3
Figure 02_image138
II-4
Figure 02_image140
IJ-1
Figure 02_image142
IJ-2
Figure 02_image144
IJ-3
Figure 02_image146
IJ-4
Figure 02_image148
IK-1
Figure 02_image150
IK-2
Figure 02_image152
IK-3
Figure 02_image154
IK-4
Figure 02_image156
IL-1
Figure 02_image158
IL-2
Figure 02_image160
IL-3
Figure 02_image162
IL-4
Figure 02_image164
IM-1
Figure 02_image166
IM-2
Figure 02_image168
IM-3
Figure 02_image170
IM-4
Figure 02_image172
IN-1
Figure 02_image174
IN-2
Figure 02_image176
IN-3
Figure 02_image178
IN-4
Figure 02_image180
Ia-1
Figure 02_image182
Ia-2
Figure 02_image184
Ia-3
Figure 02_image186
Ia-4
Figure 02_image188
Ib-1
Figure 02_image190
Ib-2
Figure 02_image192
Ib-3
Figure 02_image194
Ib-4
Figure 02_image196
Ic-1
Figure 02_image198
Ic-2
Figure 02_image200
Ic-3
Figure 02_image202
Ic-4
Figure 02_image204
Id-1
Figure 02_image206
Id-2
Figure 02_image208
Id-3
Figure 02_image210
Id-4
Figure 02_image212
Ie-1
Figure 02_image214
Ie-2
Figure 02_image216
Ie-3
Figure 02_image218
Ie-4
Figure 02_image220
If-1
Figure 02_image222
If-2
Figure 02_image224
If-3
Figure 02_image226
If-4
Figure 02_image228
Ig-1
Figure 02_image230
Ig-2
Figure 02_image232
Ig-3
Figure 02_image234
Ig-4
Figure 02_image236
Ih-1
Figure 02_image238
Ih-2
Figure 02_image240
Ih-3
Figure 02_image242
Ih-4
Figure 02_image244
II-1
Figure 02_image246
II-2
Figure 02_image248
II-3
Figure 02_image250
II-4
Figure 02_image252
Ij-1
Figure 02_image254
Ij-2
Figure 02_image256
Ij-3
Figure 02_image258
Ij-4
Figure 02_image260
Ik-1
Figure 02_image262
Ik-2
Figure 02_image264
Ik-3
Figure 02_image266
Ik-4
Figure 02_image268
Il-1
Figure 02_image270
Il-2
Figure 02_image272
Il-3
Figure 02_image274
Il-4
Figure 02_image276
Im-1
Figure 02_image278
Im-2
Figure 02_image280
Im-3
Figure 02_image282
Im-4
Figure 02_image284
In-1
Figure 02_image286
In-2
Figure 02_image288
In-3
Figure 02_image290
In-4

作為前述的Alkyl所表示的碳原子數為1~8的直鏈烷基,可以列舉出甲基、乙基、正丙基、正丁基、正戊基、正己基、正庚基、正辛基,優選為甲基、乙基或者正丙基。Examples of straight-chain alkyl groups having 1 to 8 carbon atoms represented by the aforementioned Alkyl include methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, and n-octyl. group, preferably methyl, ethyl or n-propyl.

作為前述的Alkenyl所表示的碳原子數為2~8的直鏈烯基,可以列舉出例如乙烯基、1-丙烯基、2-丙烯基、1-丁烯基、2-丁烯基、3-丁烯基、1-戊烯基、2-戊烯基、1-己烯基、2-己烯基、3-己烯基、1-庚烯基、2-庚烯基、3-庚烯基、1-辛烯基、2-辛烯基、3-辛烯基等,優選為乙烯基、1-丙烯基或者2-丙烯基。Examples of straight-chain alkenyl groups having 2 to 8 carbon atoms represented by Alkenyl include vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3 -butenyl, 1-pentenyl, 2-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 1-heptenyl, 2-heptenyl, 3-heptenyl Alkenyl, 1-octenyl, 2-octenyl, 3-octenyl and the like are preferably vinyl, 1-propenyl or 2-propenyl.

[液晶化合物的製備方法][Preparation method of liquid crystal compound]

下面,對本發明的具有負介電各向異性的液晶化合物的製備方法進行說明。Next, the preparation method of the liquid crystal compound having negative dielectric anisotropy of the present invention will be described.

需要理解的是,本發明的具有負介電各向異性的液晶化合物的製備方法,並非限於下述說明的製備方法。本領域技術人員可以採用其他的適宜的方法進行製備。It should be understood that the preparation method of the liquid crystal compound with negative dielectric anisotropy of the present invention is not limited to the preparation method described below. Those skilled in the art can use other suitable methods for preparation.

另外,下述的說明中對於式I所示的部分化合物進行說明,對於其他的化合物,本領域技術人員可以參照下述的說明並結合本領域的常規技術手段來獲得。In addition, part of the compounds represented by formula I are described in the following descriptions, and other compounds can be obtained by those skilled in the art by referring to the following descriptions in combination with conventional technical means in the field.

採用包括如下製備步驟的方法製備下述結構式所示的液晶化合物,其中,R 1、R 2、Y 1以及Y 2的定義與前述相同。

Figure 02_image292
式I-1 The liquid crystal compound represented by the following structural formula is prepared by a method comprising the following preparation steps, wherein the definitions of R 1 , R 2 , Y 1 and Y 2 are the same as above.
Figure 02_image292
Formula I-1

步驟A1:將Y 1以及Y 2取代的苯與帶有R 1取代基的環己酮在鈀金屬催化劑的存在下發生碳-芳基化反應,得到苯基環己酮化合物(A1);

Figure 02_image294
Step A1: Carbo-arylation of benzene substituted by Y1 and Y2 with cyclohexanone with R1 substituent in the presence of a palladium metal catalyst to obtain phenylcyclohexanone compound (A1);
Figure 02_image294

步驟A2:將前述的苯基環己酮化合物(A1)進一步發生鈀金屬催化氧-芳基化反應,得到苯並呋喃化合物(B1);

Figure 02_image296
Step A2: further subjecting the aforementioned phenylcyclohexanone compound (A1) to a palladium metal-catalyzed oxygen-arylation reaction to obtain a benzofuran compound (B1);
Figure 02_image296

步驟A3:將前述步驟A2獲得的苯並呋喃化合物(B1)依次在強鹼的作用下與硼酸三甲酯反應,接著進行水解和氧化反應,生成帶有R 1取代基以及酚羥基的苯並呋喃化合物(C1);

Figure 02_image298
Step A3: The benzofuran compound (B1) obtained in the aforementioned step A2 is reacted with trimethyl borate under the action of a strong base in turn, followed by hydrolysis and oxidation to generate a benzofuran compound (B1) with an R1 substituent and a phenolic hydroxyl group. furan compound (C1);
Figure 02_image298

步驟A4:將帶有酚羥基的單邊R 1取代的苯並呋喃化合物(C1)與R 2X(X表示溴或碘)於鹼性條件下反應生成兩邊對稱或不對稱的苯並呋喃化合物(I-1)。

Figure 02_image300
Step A4: Reaction of a benzofuran compound (C1) substituted by unilateral R 1 with a phenolic hydroxyl group and R 2 X (X represents bromine or iodine) under basic conditions to form a bilaterally symmetrical or asymmetrical benzofuran compound (I-1).
Figure 02_image300

採用包括如下製備步驟的方法製備前述式Ⅰ-2所示的液晶化合物,其中,R 1、R 2、Y 1以及Y 2的定義與前述相同。

Figure 02_image302
式I-2 The above-mentioned liquid crystal compound represented by the formula I-2 is prepared by a method comprising the following preparation steps, wherein the definitions of R 1 , R 2 , Y 1 and Y 2 are the same as above.
Figure 02_image302
Formula I-2

步驟B1:將Y 1以及Y 2取代的苯與帶有R 1取代基的環己酮進行鈀金屬碳-芳基化反應,得到苯基環己酮化合物(A2);

Figure 02_image304
Step B1: Palladium metal carbon-arylation reaction of benzene substituted by Y1 and Y2 and cyclohexanone with R1 substituent to obtain phenylcyclohexanone compound (A2);
Figure 02_image304

步驟B2:將前述的苯基環己酮化合物(A2)與硫化試劑反應,生成對應結構的苯基環己硫酮化合物(B2);

Figure 02_image306
Step B2: reacting the aforementioned phenylcyclohexanone compound (A2) with a vulcanizing reagent to generate a phenylcyclohexanone compound (B2) of the corresponding structure;
Figure 02_image306

步驟B3:使苯基環己硫酮化合物(B2)進行鈀金屬催化硫-芳基化反應,獲得苯並噻吩化合物(C2);

Figure 02_image308
Step B3: subjecting the phenylthiophene compound (B2) to a palladium metal-catalyzed sulfur-arylation reaction to obtain the benzothiophene compound (C2);
Figure 02_image308

步驟B4:將帶有R 1取代基的苯並噻吩化合物(C2)依序使用強鹼與硼酸三甲酯反應後,接著進行水解以及氧化反應,生成帶有R 1取代基以及酚羥基的苯並噻吩化合物(D2);

Figure 02_image310
Step B4: react the benzothiophene compound (C2) with R1 substituent with trimethyl borate in sequence, followed by hydrolysis and oxidation to generate benzene with R1 substituent and phenolic hydroxyl group Thiophene compound (D2);
Figure 02_image310

步驟B5:將帶有酚羥基的單邊R 1基取代的苯並噻吩化合物(D2)與帶有R 2X(X表示溴或碘)於鹼性條件反應生成兩邊對稱或不對稱的苯並呋喃化合物(I-2)。

Figure 02_image312
Step B5: Reaction of the benzothiophene compound (D2) substituted with a unilateral R 1 group with a phenolic hydroxyl group and R 2 X (X represents bromine or iodine) under basic conditions to form a symmetrical or asymmetrical benzothiophene compound (D2) Furan compound (I-2).
Figure 02_image312

以上,示出了前述的式I-1、式I-2所示化合物的製備方法。對於其他化合物的製備,本領域技術人員能夠參照前述製備方法,根據本領域的技術常識,改變前述製備方法中的反應原料進行製備,沒有特別的限定。The preparation methods of the compounds represented by the aforementioned formula I-1 and formula I-2 are shown above. For the preparation of other compounds, those skilled in the art can refer to the above-mentioned preparation methods, and according to the technical knowledge in the field, change the reaction raw materials in the above-mentioned preparation methods for preparation, without special limitation.

[液晶組合物][Liquid Crystal Composition]

本發明的液晶組合物中含有前述的本發明的具有負介電各向異性的液晶化合物。The liquid crystal composition of the present invention contains the aforementioned liquid crystal compound with negative dielectric anisotropy of the present invention.

本發明的液晶組合物中,可以含有一種或者多種本發明的負介電各向異性的液晶化合物,對其含量沒有特別的限定。The liquid crystal composition of the present invention may contain one or more liquid crystal compounds with negative dielectric anisotropy of the present invention, and the content thereof is not particularly limited.

本發明的液晶組合物中,本發明的負介電各向異性的液晶化合物的含量按照重量百分含量計算可以為例如20%以下。從低溫溶解性、可靠性等方面考慮,優選為15%以下的範圍。含有多種本發明的負介電各向異性的液晶化合物時,本發明的負介電各向異性的液晶化合物的含量的總和以重量百分含量計算可以為例如50%以下。In the liquid crystal composition of the present invention, the content of the liquid crystal compound with negative dielectric anisotropy of the present invention may be, for example, 20% or less by weight percentage. From the viewpoint of low-temperature solubility, reliability, etc., it is preferably in the range of 15% or less. When multiple liquid crystal compounds with negative dielectric anisotropy of the present invention are contained, the total content of the liquid crystal compounds with negative dielectric anisotropy of the present invention may be, for example, 50% or less in weight percent.

本發明的液晶組合物中,除了前述的具有負介電各向異性的液晶化合物之外,本領域技術人員還可以在不破壞其期望的液晶組合物的性能的基礎上添加其他液晶化合物。In the liquid crystal composition of the present invention, in addition to the aforementioned liquid crystal compound with negative dielectric anisotropy, those skilled in the art can also add other liquid crystal compounds on the basis of not destroying the desired properties of the liquid crystal composition.

本發明的液晶組合物中,可選的,還可以加入各種功能的摻雜劑,這些摻雜劑可以列舉出例如抗氧化劑、紫外線吸收劑、手性劑。Optionally, various functional dopants may be added to the liquid crystal composition of the present invention, and these dopants include, for example, antioxidants, ultraviolet absorbers, and chiral agents.

如前所述,本發明的液晶組合物中雖然含有本發明的具有負性介電各向異性的液晶化合物,但是本發明的組合物並非一定為負性介電各向異性,其也可以為正性介電各向異性。本領域技術人員能夠根據需要調節組合物各組分的組成及配比來獲得具有需要的各向異性的組合物。As mentioned above, although the liquid crystal composition of the present invention contains the liquid crystal compound with negative dielectric anisotropy of the present invention, the composition of the present invention does not necessarily have negative dielectric anisotropy, and it can also be Positive dielectric anisotropy. A person skilled in the art can adjust the composition and proportion of each component of the composition as required to obtain a composition with desired anisotropy.

對於本發明的液晶組合物的製備,沒有特別的限定。在含有本發明的液晶化合物的基礎上,本領域技術人員能夠根據需要,選擇適宜的其他組分進行調製。The preparation of the liquid crystal composition of the present invention is not particularly limited. On the basis of containing the liquid crystal compound of the present invention, those skilled in the art can select appropriate other components for preparation as required.

[液晶顯示器件][Liquid crystal display device]

本發明的第三方面提供一種液晶顯示器件,其只要包含前述的本發明的具有負介電各向異性的液晶化合物,或者前述的液晶組合物,就沒有特別的限定。本發明的液晶顯示器件可以為有源矩陣顯示器件,也可以為無源矩陣顯示器件。本領域技術人員能夠根據所需的性能選擇合適的液晶顯示組件、液晶顯示器的結構。The third aspect of the present invention provides a liquid crystal display device, which is not particularly limited as long as it contains the aforementioned liquid crystal compound with negative dielectric anisotropy of the present invention, or the aforementioned liquid crystal composition. The liquid crystal display device of the present invention may be an active matrix display device or a passive matrix display device. Those skilled in the art can select a suitable liquid crystal display component and structure of the liquid crystal display according to the required performance.

實施例Example

實施例1 LOY-3-O2

Figure 02_image314
Example 1 LOY-3-O2
Figure 02_image314

合成路線:

Figure 02_image316
synthetic route:
Figure 02_image316

在反應瓶中加入1.13 g碳酸銫(3.45 mmol)、7.2 mg Pd 2(dba) 3(0.008 mmol)和11mg Xantphos (0.019 mmol, 4,5-雙二苯基膦-9,9-二甲基氧雜蒽),之後將反應瓶氣體置換成氮氣,加入4 mL無水二噁烷、0.5 g 1-溴-3,4-二氟-2-碘苯(1.57 mmol)和0.44g 3-丙基環己酮 (3.14 mmol)。接著在80°C油浴反應24小時。待反應液冷卻後,用乙醚和水進行萃取,收集有機層,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物A3 0.41g。 Add 1.13 g cesium carbonate (3.45 mmol), 7.2 mg Pd2 (dba) 3 (0.008 mmol) and 11 mg Xantphos (0.019 mmol, 4,5-bisdiphenylphosphine-9,9-dimethyl xanthene), then replace the reaction bottle with nitrogen, add 4 mL of anhydrous dioxane, 0.5 g of 1-bromo-3,4-difluoro-2-iodobenzene (1.57 mmol) and 0.44 g of 3-propyl Cyclohexanone (3.14 mmol). Then react in an oil bath at 80° C. for 24 hours. After the reaction solution was cooled, it was extracted with diethyl ether and water, and the organic layer was collected, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.41 g of product A3.

1H-NMR(500MHz, CDCl 3, ppm):7.13(d, 1H)、6.66 (d, 1H)、3.50 (t, 1H)、2.31 (m, 2H) 、2.21 (m, 2H) 、1.86 (m, 2H) 、1.79 (m, 1H)、1.33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.13 (d, 1H), 6.66 (d, 1H), 3.50 (t, 1H), 2.31 (m, 2H) , 2.21 (m, 2H) , 1.86 ( m, 2H), 1.79 (m, 1H), 1.33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物A3(1.51 mmol)、0.69g碳酸銫(2.11 mmol)、34.6mg Pd 2(dba) 3(0.038 mmol)及40.7mg DPEPhos(0.076 mmol, (2-二苯基膦苯基)醚)於反應瓶內,之後將反應瓶氣體置換成氮氣。接著加入4mL無水甲苯後,在100℃油浴反應20小時,待冷卻後將反應液以矽藻土過濾、減壓濃縮,將濃縮液以柱層析純化,可得到產物B3 0.36g。 Take 0.5g compound A3 (1.51 mmol), 0.69g cesium carbonate (2.11 mmol), 34.6mg Pd 2 (dba) 3 (0.038 mmol) and 40.7mg DPEPhos (0.076 mmol, (2-diphenylphosphine phenyl) ether ) in the reaction bottle, and then replace the reaction bottle gas with nitrogen. After adding 4 mL of anhydrous toluene, react in an oil bath at 100°C for 20 hours. After cooling, filter the reaction solution with diatomaceous earth, concentrate under reduced pressure, and purify the concentrated solution by column chromatography to obtain 0.36 g of product B3.

1H-NMR(500MHz, CDCl 3, ppm):7.17(d, 1H)、6.88 (d, 1H)、2.60 (m, 2H)、2.48 (m, 2H)、1.86 (m, 1H)、1.71(m, 2H)、1.33-1.25(m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.17(d, 1H), 6.88 (d, 1H), 2.60 (m, 2H), 2.48 (m, 2H), 1.86 (m, 1H), 1.71( m, 2H), 1.33-1.25(m, 4H), 0.96 (t, 3H).

取0.5g化合物B3 (2.0 mmol)溶解在12ml THF中,將反應瓶降溫至-78℃後加入1.4ml的含1.5M n-丁基鋰(2.1 mmol)的己烷溶液,之後降溫至0℃反應30分鐘。接著在-78℃下加入0.22g 硼酸三甲酯 (2.1 mmol)後,將溫度升到室溫反應1小時。之後加入1ml 醋酸以及0.25ml 30% H 2O 2,接著繼續攪拌至隔日。反應液用乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將得到的濃縮液進行柱層析,可得到產物C3 0.45g。 Dissolve 0.5g of compound B3 (2.0 mmol) in 12ml of THF, cool the reaction flask to -78°C, add 1.4ml of hexane solution containing 1.5M n-butyl lithium (2.1 mmol), then cool down to 0°C React for 30 minutes. Then, after adding 0.22 g of trimethyl borate (2.1 mmol) at -78°C, the temperature was raised to room temperature for 1 hour of reaction. After that, 1 ml of acetic acid and 0.25 ml of 30% H 2 O 2 were added, and the stirring was continued until the next day. The reaction solution was extracted with ethyl acetate and water, and the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The obtained concentrate was subjected to column chromatography to obtain 0.45 g of product C3.

1H-NMR(500MHz, CDCl 3, ppm):6.64(s, 1H)、5.0(s, 1H)、2.60 (m, 2H)、2.48 (m, 2H)、1.86 (m, 1H)、1.71 (m, 2H)、1.33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 6.64(s, 1H), 5.0(s, 1H), 2.60 (m, 2H), 2.48 (m, 2H), 1.86 (m, 1H), 1.71 ( m, 2H), 1.33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物C3(1.88 mmol)、0.52g 碳酸鉀(3.76 mmol)及0.35g 碘乙烷 (2.26 mmol)於反應瓶內,加入6mL二甲基甲醯胺,在70℃油浴反應3小時,待反應液降溫後以水及乙酸乙酯進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物D3 0.56g。 Take 0.5g of compound C3 (1.88 mmol), 0.52g of potassium carbonate (3.76 mmol) and 0.35g of iodoethane (2.26 mmol) in a reaction flask, add 6mL of dimethylformamide, and react in an oil bath at 70°C for 3 hours , After the reaction solution cooled down, it was extracted with water and ethyl acetate, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.56 g of product D3.

製備得到的化合物D3(LOY-3-O2)的質譜、核磁共振譜數據如下。根據測試結果,化合物D3為LOY-3-O2所示結構。The mass spectrum and nuclear magnetic resonance spectrum data of the prepared compound D3 (LOY-3-O2) are as follows. According to the test results, compound D3 has the structure shown in LOY-3-O2.

MS(EI, m/z): 206, 265, 294。MS (EI, m/z): 206, 265, 294.

1H-NMR(500MHz, CDCl 3, ppm):6.68(d, 1H)、3.98 (q, 2H)、2.6 (m, 2H)、2.48 (m, 2H)、1.86(m, 1H)、1.71 (m, 2H)、1.33-1.25 (m, 7H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 6.68(d, 1H), 3.98 (q, 2H), 2.6 (m, 2H), 2.48 (m, 2H), 1.86(m, 1H), 1.71 ( m, 2H), 1.33-1.25 (m, 7H), 0.96 (t, 3H).

13C-NMR(500MHz, CDCl 3, ppm):153.6、150.3、143.5、142.8、129.5、112.1、109.6、93.7、64.7、34.3、32.2、31.6、29.9、20、17.3、14.8、14.4。 13 C-NMR (500 MHz, CDCl 3 , ppm): 153.6, 150.3, 143.5, 142.8, 129.5, 112.1, 109.6, 93.7, 64.7, 34.3, 32.2, 31.6, 29.9, 20, 17.3, 14.8, 14.4.

實施例2Example 2

LSY-3-O2

Figure 02_image318
LSY-3-O2
Figure 02_image318

合成路線:

Figure 02_image320
synthetic route:
Figure 02_image320

在反應瓶中加入1.13 g碳酸銫(3.45 mmol) 、7.2 mg Pd 2(dba) 3(0.008 mmol)和11mg Xantphos (0.019 mmol, 4,5-雙二苯基膦-9,9-二甲基氧雜蒽),之後將反應瓶氣體置換成氮氣,加入4 mL無水二噁烷 、0.5 g 1-溴-3,4-二氟-2-碘代苯(1.57 mmol) 和0.44g 3-丙基環己酮 (3.14 mmol)。接著在80°C油浴反應24小時。待反應液冷卻後,用乙醚和水進行萃取,收集有機層,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物A4 0.41g。 Add 1.13 g cesium carbonate (3.45 mmol), 7.2 mg Pd 2 (dba) 3 (0.008 mmol) and 11 mg Xantphos (0.019 mmol, 4,5-bisdiphenylphosphine-9,9-dimethyl xanthene), then replace the reaction bottle with nitrogen, add 4 mL of anhydrous dioxane, 0.5 g of 1-bromo-3,4-difluoro-2-iodobenzene (1.57 mmol) and 0.44 g of 3-propane Cyclohexanone (3.14 mmol). Then react in an oil bath at 80° C. for 24 hours. After the reaction solution was cooled, it was extracted with diethyl ether and water, and the organic layer was collected, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.41 g of product A4.

1H-NMR(500MHz, CDCl 3, ppm): 7.13(d, 1H)、6.66 (d, 1H)、3.50 (t, 1H)、2.31 (m, 2H) 、2.21 (m, 2H) 、1.86 (m, 2H) 、1.79 (m, 1H)、1.33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.13(d, 1H), 6.66 (d, 1H), 3.50 (t, 1H), 2.31 (m, 2H) , 2.21 (m, 2H) , 1.86 ( m, 2H), 1.79 (m, 1H), 1.33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物A4 (1.51 mmol)及0.054g五硫化二磷(0.38 mmol)於反應瓶內,之後將反應瓶氣體置換成氮氣,再加入6mL無水甲苯於室溫下攪拌30分鐘。接著再加入0.42g六甲基二矽氧烷(2.57 mmol),並且在90℃油浴反應24小時。之後待反應液冷卻後,把反應液以矽膠短管柱過濾、減壓濃縮,可得產物B4 0.37g。Take 0.5g of compound A4 (1.51 mmol) and 0.054g of phosphorus pentasulfide (0.38 mmol) in the reaction bottle, then replace the gas in the reaction bottle with nitrogen, then add 6 mL of anhydrous toluene and stir at room temperature for 30 minutes. Next, 0.42 g of hexamethyldisiloxane (2.57 mmol) was added and reacted in an oil bath at 90° C. for 24 hours. After the reaction solution was cooled, the reaction solution was filtered through a short silica gel column and concentrated under reduced pressure to obtain 0.37 g of the product B4.

1H-NMR(500MHz, CDCl 3, ppm):7.13 (d, 1H)、6.66 (d, 1H)、2.8 (t, 1H)、1.7 (m, 2H)、1.5 (m, 1H)、1. 40 (m, 2H)、1.38 (m, 2H)、1.33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.13 (d, 1H), 6.66 (d, 1H), 2.8 (t, 1H), 1.7 (m, 2H), 1.5 (m, 1H), 1. 40 (m, 2H), 1.38 (m, 2H), 1.33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物B4 (1.44 mmol)、0.66g碳酸銫(2.02 mmol)、33mg Pd 2(dba) 3(0.036 mmol)及38.8mg DPEPhos(0.072 mmol,(2-二苯基膦苯基)醚)於反應瓶內,之後將反應瓶氣體置換成氮氣。接著加入4mL無水甲苯後,在100℃油浴反應20小時,待冷卻後將反應液以矽藻土過濾、減壓濃縮,將濃縮液以柱層析純化,可得到產物C4 0.36g。 Take 0.5g compound B4 (1.44 mmol), 0.66g cesium carbonate (2.02 mmol), 33mg Pd 2 (dba) 3 (0.036 mmol) and 38.8 mg DPEPhos (0.072 mmol, (2-diphenylphosphine phenyl) ether) In the reaction bottle, the gas in the reaction bottle was replaced with nitrogen. After adding 4 mL of anhydrous toluene, react in an oil bath at 100°C for 20 hours. After cooling, filter the reaction solution with diatomaceous earth, concentrate under reduced pressure, and purify the concentrated solution by column chromatography to obtain 0.36 g of product C4.

1H-NMR(500MHz, CDCl 3, ppm):7.61(d, 1H)、7.00 (d, 1H)、2.63 (m, 2H)、 2.50 (m, 2H) 、1.86 (m, 1H)、1.71(m, 2H)、1. 33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.61(d, 1H), 7.00 (d, 1H), 2.63 (m, 2H), 2.50 (m, 2H) , 1.86 (m, 1H), 1.71( m, 2H), 1. 33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物C (1.88 mmol)溶解在13ml THF中,將反應瓶降溫至-78℃後加入1.3ml的含1.5M n-丁基鋰(1.97 mmol)的己烷溶液,之後升溫至0℃反應30分鐘。接著在-78℃下加入0.2g 硼酸三甲酯 (1.97 mmol)後,將溫度升溫到室溫反應1小時。之後加入1ml 醋酸以及0.22ml 30% H 2O 2,接著繼續攪拌至隔日。反應液用乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將得到的濃縮液進行柱層析,可得到產物D4 0.45g。 Dissolve 0.5g of compound C (1.88 mmol) in 13ml of THF, cool the reaction flask to -78°C, add 1.3ml of 1.5M n-butyllithium (1.97 mmol) in hexane, then heat up to 0°C React for 30 minutes. Next, after adding 0.2 g of trimethyl borate (1.97 mmol) at -78°C, the temperature was raised to room temperature for 1 hour of reaction. After that, 1 ml of acetic acid and 0.22 ml of 30% H 2 O 2 were added, and the stirring was continued until the next day. The reaction solution was extracted with ethyl acetate and water, and the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The obtained concentrate was subjected to column chromatography to obtain 0.45 g of product D4.

1H-NMR(500MHz, CDCl 3, ppm):7.08(s, 1H)、5.0(s, 1H)、2.63 (m, 2H)、2.50 (m, 2H)、1.86 (m, 1H)、1.71 (m, 2H)、1.33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.08(s, 1H), 5.0(s, 1H), 2.63 (m, 2H), 2.50 (m, 2H), 1.86 (m, 1H), 1.71 ( m, 2H), 1.33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物D4(1.77 mmol)、0.49g 碳酸鉀(3.54 mmol)及0.33g 碘乙烷 (2.12 mmol)於反應瓶內,加入5mL二甲基甲醯胺,在70℃油浴反應3小時,待反應液降溫後以水及乙酸乙酯進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物E4 0.44g。 Take 0.5g of compound D4 (1.77 mmol), 0.49g of potassium carbonate (3.54 mmol) and 0.33g of iodoethane (2.12 mmol) in a reaction flask, add 5mL of dimethylformamide, and react in an oil bath at 70°C for 3 hours , After the reaction solution cooled down, it was extracted with water and ethyl acetate, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.44 g of product E4.

製備得到的化合物E4 (LSY-3-O2)進行質譜、核磁共振譜測試,測試得到的數據如下。根據測試結果,化合物E4為LSY-3-O2所示結構。The prepared compound E4 (LSY-3-O2) was tested by mass spectrometry and nuclear magnetic resonance spectrum, and the data obtained by the test are as follows. According to the test results, compound E4 has the structure shown in LSY-3-O2.

MS(EI, m/z): 222, 265, 310。MS (EI, m/z): 222, 265, 310.

1H-NMR(500MHz, CDCl 3, ppm): 7.12(s, 1H)、3.98 (q, 2H)、2.63 (m, 2H)、2.60 (m, 2H)、1.86 (m, 1H)、1.71(m, 2H)、1.33-1.25 (m, 7H)、0.98 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.12(s, 1H), 3.98 (q, 2H), 2.63 (m, 2H), 2.60 (m, 2H), 1.86 (m, 1H), 1.71( m, 2H), 1.33-1.25 (m, 7H), 0.98 (t, 3H).

13C-NMR(500MHz, CDCl 3, ppm):145.6、143.1、141.8、136、131.5、130.6、121.9、101、64.7、36.7、34.7、31.6、27.7、22.8、20.6、15.1、14.6。 13 C-NMR (500 MHz, CDCl 3 , ppm): 145.6, 143.1, 141.8, 136, 131.5, 130.6, 121.9, 101, 64.7, 36.7, 34.7, 31.6, 27.7, 22.8, 20.6, 15.1, 14.6.

實施例3Example 3

LSP[F,OT]-3-O2

Figure 02_image322
LSP[F,OT]-3-O2
Figure 02_image322

合成路線:

Figure 02_image324
synthetic route:
Figure 02_image324

在反應瓶中加入0.93g碳酸銫(2.86 mmol) 、5.95 mg Pd 2(dba) 3(0.065 mmol)和9.23mg Xantphos (0.016 mmol, 4,5-雙二苯基膦-9,9-二甲基氧雜蒽),之後將反應瓶氣體置換成氮氣,加入4 mL無水二噁烷、0.5g 1-溴-3-氟-2-碘代-4-(三氟甲氧基)苯(1.30 mmol)和0.36g 3-丙基環己酮(2.6 mmol)。接著在80°C油浴反應24小時。待反應液冷卻後,用乙醚和水進行萃取,收集有機層,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物A5 0.40g。 Add 0.93 g cesium carbonate (2.86 mmol), 5.95 mg Pd 2 (dba) 3 (0.065 mmol) and 9.23 mg Xantphos (0.016 mmol, 4,5-bisdiphenylphosphine-9,9-dimethyl oxanthene), then replace the gas in the reaction bottle with nitrogen, add 4 mL of anhydrous dioxane, 0.5 g of 1-bromo-3-fluoro-2-iodo-4-(trifluoromethoxy)benzene (1.30 mmol) and 0.36 g 3-propylcyclohexanone (2.6 mmol). Then react in an oil bath at 80° C. for 24 hours. After the reaction solution was cooled, it was extracted with diethyl ether and water, and the organic layer was collected, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.40 g of product A5.

1H-NMR(500MHz, CDCl 3, ppm):7.04(d, 1H)、6.46 (d, 1H)、3.50 (t, 1H)、2.31(m, 2H) 、2.21(m, 2H) 、1.88(m, 2H) 、1.79(m, 1H) 、1.33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.04(d, 1H), 6.46 (d, 1H), 3.50 (t, 1H), 2.31(m, 2H) , 2.21(m, 2H) , 1.88( m, 2H), 1.79(m, 1H), 1.33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物A5 (1.26 mmol)及0.045g五硫化二磷(0.31 mmol)於反應瓶內,之後將反應瓶氣體置換成氮氣,再加入5mL無水甲苯於室溫下攪拌30分鐘。接著再加入0.35g六甲基二矽氧烷(2.14 mmol),並且在90℃油浴反應24小時。之後待反應液冷卻後,把反應液以矽膠短管柱過濾、減壓濃縮,可得產物B5 0.36g。Take 0.5g of compound A5 (1.26 mmol) and 0.045g of phosphorus pentasulfide (0.31 mmol) in the reaction bottle, then replace the gas in the reaction bottle with nitrogen, then add 5mL of anhydrous toluene and stir at room temperature for 30 minutes. Next, 0.35 g of hexamethyldisiloxane (2.14 mmol) was added, and reacted in an oil bath at 90° C. for 24 hours. After the reaction solution was cooled, the reaction solution was filtered through a short silica gel column and concentrated under reduced pressure to obtain 0.36 g of product B5.

1H-NMR(500MHz, CDCl 3, ppm):7.04(d, 1H)、6.46 (d, 1H)、2.8 (t, 1H)、1.7 (m, 2H)、1.5 (m, 1H) 、1.4 (m, 2H)、1.38(m, 2H) 、1.33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.04 (d, 1H), 6.46 (d, 1H), 2.8 (t, 1H), 1.7 (m, 2H), 1.5 (m, 1H) , 1.4 ( m, 2H), 1.38(m, 2H), 1.33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物B5 (1.21 mmol)、0.55g碳酸銫(1.69 mmol)、27.7mg Pd 2(dba) 3(0.03 mmol)及32.6mg DPEPhos(0.061 mmol,(2-二苯基膦苯基)醚)於反應瓶內,之後將反應瓶氣體置換成氮氣。接著加入4mL無水甲苯後,在100℃油浴反應20小時,待冷卻後將反應液以矽藻土過濾、減壓濃縮,將濃縮液以柱層析純化,可得到產物C5 0.38g。 Take 0.5g compound B5 (1.21 mmol), 0.55 g cesium carbonate (1.69 mmol), 27.7 mg Pd 2 (dba) 3 (0.03 mmol) and 32.6 mg DPEPhos (0.061 mmol, (2-diphenylphosphine phenyl) ether ) in the reaction bottle, and then replace the reaction bottle gas with nitrogen. Then add 4mL of anhydrous toluene, react in an oil bath at 100°C for 20 hours, after cooling, filter the reaction solution with diatomaceous earth, concentrate under reduced pressure, and purify the concentrated solution by column chromatography to obtain 0.38g of product C5.

1H-NMR(500MHz, CDCl 3, ppm):7.52(d, 1H)、6.8 (d, 1H)、2.63 (m, 2H)、2.5 (m, 2H)、1.86 (m, 1H)、1.71 (m, 2H)、1. 35-1.24 (m, 4H)、0.99 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.52 (d, 1H), 6.8 (d, 1H), 2.63 (m, 2H), 2.5 (m, 2H), 1.86 (m, 1H), 1.71 ( m, 2H), 1. 35-1.24 (m, 4H), 0.99 (t, 3H).

取0.5g化合物C5 (1.5 mmol)溶解在10ml THF中,將反應瓶降溫至-78℃後加入1.05ml的含1.5M n-丁基鋰(1.58 mmol)的己烷溶液,之後升溫至0℃反應30分鐘。接著在-78℃下加入0.16g 硼酸三甲酯 (1.58mmol)後,將溫度回到室溫反應1小時。之後加入1ml 醋酸以及0.18ml 30% H 2O 2,接著繼續攪拌至隔日。反應液用乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將得到的濃縮液進行柱層析,可得到產物D5 0.44g。 Dissolve 0.5g of compound C5 (1.5 mmol) in 10ml of THF, cool the reaction flask to -78°C, add 1.05ml of hexane solution containing 1.5M n-butyllithium (1.58 mmol), and then raise the temperature to 0°C React for 30 minutes. Then, after adding 0.16 g of trimethyl borate (1.58 mmol) at -78°C, the temperature was returned to room temperature for 1 hour of reaction. After that, 1 ml of acetic acid and 0.18 ml of 30% H 2 O 2 were added, and the stirring was continued until the next day. The reaction solution was extracted with ethyl acetate and water, and the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The obtained concentrate was subjected to column chromatography to obtain 0.44 g of product D5.

1H-NMR(500MHz, CDCl 3, ppm):6.99(s, 1H)、5.0(s, 1H)、2.63 (m, 2H)、2.60 (m, 2H)、1.86 (m, 1H)、1.71 (m, 2H)、1.33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 6.99(s, 1H), 5.0(s, 1H), 2.63 (m, 2H), 2.60 (m, 2H), 1.86 (m, 1H), 1.71 ( m, 2H), 1.33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物D5(1.44 mmol)、0.4g 碳酸鉀(2.88 mmol)及0.27g 碘乙烷 (1.73 mmol)於反應瓶內,加入5mL二甲基甲醯胺,在70℃油浴反應3小時,待反應液降溫後以水及乙酸乙酯進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物E5 0.43g。製備得到的化合物E (LSP(FOT)-3-O2)進行質譜、核磁共振譜測試,測試得到的數據如下。根據測試結果,化合物E5為LSP(FOT)-3-O2所示結構。 Take 0.5g of compound D5 (1.44 mmol), 0.4g of potassium carbonate (2.88 mmol) and 0.27g of ethyl iodide (1.73 mmol) in a reaction flask, add 5mL of dimethylformamide, and react in an oil bath at 70°C for 3 hours , After the reaction solution cooled down, it was extracted with water and ethyl acetate, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.43 g of product E5. The prepared compound E (LSP(FOT)-3-O2) was subjected to mass spectrometry and nuclear magnetic resonance spectrometry tests, and the data obtained from the tests were as follows. According to the test results, the compound E5 has the structure shown in LSP(FOT)-3-O2.

MS(EI. m/z): 288, 333, 376。MS (EI. m/z): 288, 333, 376.

1H-NMR(500MHz, CDCl 3, ppm): 7.03(s, 1H)、3.98 (q, 2H)、2.63 (m, 2H)、2.60 (m, 2H)、1.86 (m, 1H)、1.71(m, 2H)、1.35-1.26 (m, 7H)、0.97 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.03(s, 1H), 3.98 (q, 2H), 2.63 (m, 2H), 2.60 (m, 2H), 1.86 (m, 1H), 1.71( m, 2H), 1.35-1.26 (m, 7H), 0.97 (t, 3H).

13C-NMR(500MHz, CDCl 3):147.6、143.6、141.8、132.7、131.8、130.1、122.1、121.3、101.4、66.2、36.7、34.7、31.6、27.7、22.8、20.6、15.2、14.6 。 13 C-NMR (500 MHz, CDCl 3 ): 147.6, 143.6, 141.8, 132.7, 131.8, 130.1, 122.1, 121.3, 101.4, 66.2, 36.7, 34.7, 31.6, 27.7, 22.8, 20.6, 15.2, 14.6.

實施例4Example 4

LSP[TO,OT]-3-O2

Figure 02_image326
LSP[TO,OT]-3-O2
Figure 02_image326

合成路線:

Figure 02_image328
synthetic route:
Figure 02_image328

在反應瓶中加入0.80 g碳酸銫(2.44 mmol) 、5.08 mg Pd 2(dba) 3(0.0056 mmol)和7.7 mg Xantphos (0.133 mmol, 4,5-雙二苯基膦-9,9-二甲基氧雜蒽),之後將反應瓶氣體置換成氮氣,加入3 mL無水二噁烷 、0.5 g 1-溴-2-碘-3,4-雙(三氟甲氧基)苯(1.11 mmol)和0.31 g 3-丙基環己酮 (2.22 mmol)。接著在80°C油浴反應24小時。待反應液冷卻後,用乙醚和水進行萃取,收集有機層,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物A6 0.40g。 Add 0.80 g cesium carbonate (2.44 mmol), 5.08 mg Pd 2 (dba) 3 (0.0056 mmol) and 7.7 mg Xantphos (0.133 mmol, 4,5-bisdiphenylphosphine-9,9-dimethyl oxanthene), then replace the reaction bottle gas with nitrogen, add 3 mL of anhydrous dioxane, 0.5 g 1-bromo-2-iodo-3,4-bis(trifluoromethoxy)benzene (1.11 mmol) and 0.31 g 3-propylcyclohexanone (2.22 mmol). Then react in an oil bath at 80° C. for 24 hours. After the reaction solution was cooled, it was extracted with diethyl ether and water, and the organic layer was collected, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.40 g of product A6.

1H-NMR(500MHz, CDCl 3, ppm):6.83(d, 1H)、6.37 (d, 1H)、3.50 (t, 1H)、2.36 (m, 2H)、2.21 (m, 2H)、1.89 (m, 2H)、1.77 (m, 1H)、1.36-1.24 (m, 4H)、0.97 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 6.83 (d, 1H), 6.37 (d, 1H), 3.50 (t, 1H), 2.36 (m, 2H), 2.21 (m, 2H), 1.89 ( m, 2H), 1.77 (m, 1H), 1.36-1.24 (m, 4H), 0.97 (t, 3H).

取0.5g化合物A6 (1.08mmol)及0.038g五硫化二磷(0.27mmol)於反應瓶內,之後將反應瓶氣體置換成氮氣,再加入5mL無水甲苯於室溫下攪拌30分鐘。接著再加入0.3g六甲基二矽氧烷(1.84mmol),並且在90℃油浴反應24小時。之後待反應液冷卻後,把反應液以矽膠短管柱過濾、減壓濃縮,可得產物B6 0.34g。Take 0.5g of compound A6 (1.08mmol) and 0.038g of phosphorus pentasulfide (0.27mmol) in the reaction bottle, then replace the gas in the reaction bottle with nitrogen, then add 5mL of anhydrous toluene and stir at room temperature for 30 minutes. Next, 0.3 g of hexamethyldisiloxane (1.84 mmol) was added, and reacted in an oil bath at 90° C. for 24 hours. After the reaction solution was cooled, the reaction solution was filtered through a short silica gel column and concentrated under reduced pressure to obtain 0.34 g of the product B6.

1H-NMR(500MHz, CDCl 3, ppm):6.85(d, 1H)、6.38 (d, 1H)、2.8 (t, 1H)、1.7 (m, 2H)、1.5 (m, 1H)、1.4 (m, 2H)、1.38 (m, 2H)、1. 33-1.25 (m, 4H)、0.95 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 6.85 (d, 1H), 6.38 (d, 1H), 2.8 (t, 1H), 1.7 (m, 2H), 1.5 (m, 1H), 1.4 ( m, 2H), 1.38 (m, 2H), 1. 33-1.25 (m, 4H), 0.95 (t, 3H).

取0.5g化合物0.5g化合物B (1.04 mmol)、0.48g碳酸銫(1.46 mmol)、24mg Pd 2(dba) 3(0.026 mmol)及28mg DPEPhos(0.052 mmol,(2-二苯基膦苯基)醚)於反應瓶內,之後將反應瓶氣體置換成氮氣。接著加入3mL無水甲苯後,在100℃油浴反應20小時,待冷卻後將反應液以矽藻土過濾、減壓濃縮,將濃縮液以柱層析純化,可得到產物C6 0.4g。 Take 0.5g compound 0.5g compound B (1.04 mmol), 0.48g cesium carbonate (1.46 mmol), 24 mg Pd 2 (dba) 3 (0.026 mmol) and 28 mg DPEPhos (0.052 mmol, (2-diphenylphosphine phenyl) ether) in the reaction bottle, and then the reaction bottle gas was replaced with nitrogen. After adding 3mL of anhydrous toluene, react in an oil bath at 100°C for 20 hours. After cooling, filter the reaction solution with diatomaceous earth, concentrate under reduced pressure, and purify the concentrated solution by column chromatography to obtain 0.4 g of product C6.

1H-NMR(500MHz, CDCl 3, ppm):7.31(d, 1H)、6.71 (d, 1H)、2.63 (m, 2H)、2.50 (m, 2H)、1.86 (m, 1)、1.7 (m, 2H)、1.34-1.23(m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.31 (d, 1H), 6.71 (d, 1H), 2.63 (m, 2H), 2.50 (m, 2H), 1.86 (m, 1), 1.7 ( m, 2H), 1.34-1.23 (m, 4H), 0.96 (t, 3H).

取0.5g化合物C6 (1.2 6mmol)溶解在10ml THF中,將反應瓶降溫至-78℃後加入1.05ml的含1.5M n-丁基鋰(1.32 mmol)的丁烷,之後升溫至0℃反應30分鐘。接著在-78℃下加入0.14g 硼酸三甲酯 (1.32mmol)後,將溫度回到室溫反應1小時。之後加入1ml 醋酸以及0.15ml 30% H 2O 2,接著繼續攪拌至隔日。反應液用乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將得到的濃縮液進行柱層析,可得到產物D6 0.45g。 Dissolve 0.5g of compound C6 (1.2 6mmol) in 10ml of THF, cool the reaction flask to -78°C, add 1.05ml of butane containing 1.5M n-butyllithium (1.32 mmol), then heat up to 0°C for reaction 30 minutes. Then, after adding 0.14 g of trimethyl borate (1.32 mmol) at -78°C, the temperature was returned to room temperature for 1 hour of reaction. After that, 1 ml of acetic acid and 0.15 ml of 30% H 2 O 2 were added, and the stirring was continued until the next day. The reaction solution was extracted with ethyl acetate and water, and the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The obtained concentrate was subjected to column chromatography to obtain 0.45 g of product D6.

1H-NMR(500MHz, CDCl 3, ppm):6.78(s, 1H)、5.0(s, 1H)、2.63 (m, 2H)、2.50 (m, 2H)、1.86(m, 1H)、1.7 (m, 2H)、1.33-1.25 (m, 4H)、0.96 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 6.78(s, 1H), 5.0(s, 1H), 2.63 (m, 2H), 2.50 (m, 2H), 1.86(m, 1H), 1.7 ( m, 2H), 1.33-1.25 (m, 4H), 0.96 (t, 3H).

取0.5g化合物D6 (1.21 mmol)、0.33g 碳酸鉀(2.42 mmol)及0.23g 碘乙烷 (1.45 mmol)於反應瓶內,加入5mL二甲基甲醯胺,在70℃油浴反應3小時,待反應液降溫後以水及乙酸乙酯進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物E6 0.38g。製備得到的化合物進行質譜、核磁共振譜測試,測試得到的數據如下。根據測試結果,化合物E6為LSP(TOOT)-3-O2所示結構。 Take 0.5g of compound D6 (1.21 mmol), 0.33g of potassium carbonate (2.42 mmol) and 0.23g of ethyl iodide (1.45 mmol) in a reaction flask, add 5mL of dimethylformamide, and react in an oil bath at 70°C for 3 hours , After the reaction solution cooled down, it was extracted with water and ethyl acetate, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.38 g of product E6. The prepared compound was tested by mass spectrometry and nuclear magnetic resonance spectrum, and the data obtained by the test are as follows. According to the test results, the compound E6 has the structure shown in LSP(TOOT)-3-O2.

MS(EI, m/z): 356, 399, 442。MS (EI, m/z): 356, 399, 442.

1H-NMR(500MHz, CDCl 3, ppm):6.82 (s, 1H)、3.98 (q, 2H)、2.63 (m, 2H)、2.60 (m, 2H)、1.86 (m, 1H)、1.71 (m, 2H)、1.32-1.23 (m, 7H)、0.98 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 6.82 (s, 1H), 3.98 (q, 2H), 2.63 (m, 2H), 2.60 (m, 2H), 1.86 (m, 1H), 1.71 ( m, 2H), 1.32-1.23 (m, 7H), 0.98 (t, 3H).

13C-NMR(500MHz, CDCl 3):147、142.5、140.8、132.1、131.1、129.1、122.5、122.4、119.9、97.1、65、36.7、34.7、31.6、27.2、22.7、20.6、14.6、13.9。 13 C-NMR (500 MHz, CDCl 3 ): 147, 142.5, 140.8, 132.1, 131.1, 129.1, 122.5, 122.4, 119.9, 97.1, 65, 36.7, 34.7, 31.6, 27.2, 22.7, 20.6, 14.6, 13.9.

實施例5Example 5

LSP[T,F]-3-O2

Figure 02_image330
LSP[T,F]-3-O2
Figure 02_image330

合成路線:

Figure 02_image332
synthetic route:
Figure 02_image332

取1.0g 3-丙基環己-1-酮 (7.14 mmol)、1.25g 1-溴-4-氟-2-碘-3-(三氟甲基)苯(3.39 mmol) 、2.33g 碳酸銫 (7.14 mmol)、 73mg Pd 2(dba) 3(0.08 mmol)以及14.8mg Xantphos (0.16 mmol, 4,5-雙二苯基膦-9,9-二甲基氧雜蒽)於反應瓶中,並且將氣體置換成氮氣。接著加入15ml 無水二噁烷進行攪拌,然後加熱至90℃、反應24小時。等待溫度回到室溫後,將反應液以乙酸乙酯以及水進行萃取、收集有機層,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物A7 0.93g。 Take 1.0g 3-propylcyclohexan-1-one (7.14 mmol), 1.25g 1-bromo-4-fluoro-2-iodo-3-(trifluoromethyl)benzene (3.39 mmol), 2.33g cesium carbonate (7.14 mmol), 73mg Pd 2 (dba) 3 (0.08 mmol) and 14.8mg Xantphos (0.16 mmol, 4,5-bisdiphenylphosphine-9,9-dimethyloxanthene) in the reaction flask, And the gas was replaced with nitrogen. Next, 15 ml of anhydrous dioxane was added and stirred, then heated to 90° C., and reacted for 24 hours. After waiting for the temperature to return to room temperature, the reaction solution was extracted with ethyl acetate and water, and the organic layer was collected. After that, the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.93 g of product A7.

1H-NMR(500MHz, CDCl 3, ppm):7.52 (d, 1H)、7.02 (d, 1H)、3.5 (t, 1H)、2.31~2.21 (m, 2H)、2.06~1.96 (m, 2H)、1.72 (m, 2H)、1.48 (q, 1H)、1.32 (q, 2H)、1.18 (q, 2H)、0.91 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.52 (d, 1H), 7.02 (d, 1H), 3.5 (t, 1H), 2.31~2.21 (m, 2H), 2.06~1.96 (m, 2H ), 1.72 (m, 2H), 1.48 (q, 1H), 1.32 (q, 2H), 1.18 (q, 2H), 0.91 (t, 3H).

取0.5g化合物A7 (1.31 mmol)及73mg 五硫化二磷(0.33 mmol)於反應瓶中,之後將氣體置換成氮氣,加入8mL無水甲苯,室溫下攪拌30分鐘。接著再加入0.36g 六甲基二矽氧烷(2.23 mmol),移至90°C油浴下攪拌24小時。待反應液冷卻後,將反應液以矽膠短管柱過濾,後續把溶液減壓濃縮,可得到產物B7 0.32g。Take 0.5 g of compound A7 (1.31 mmol) and 73 mg of phosphorus pentasulfide (0.33 mmol) in a reaction flask, then replace the gas with nitrogen, add 8 mL of anhydrous toluene, and stir at room temperature for 30 minutes. Next, 0.36 g of hexamethyldisiloxane (2.23 mmol) was added, and the mixture was moved to 90° C. in an oil bath and stirred for 24 hours. After the reaction solution was cooled, the reaction solution was filtered with a short silica gel column, and then the solution was concentrated under reduced pressure to obtain 0.32 g of product B7.

1H-NMR(500MHz, CDCl 3, ppm):7.55 (d, 1H)、7.08 (d, 1H)、 2.75 (t, 1H)、1.73 (q, 1H)、1.51 (q, 1H)、1.35~1.18 (m, 7H)、1.02 (q, 2H)、0.91 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.55 (d, 1H), 7.08 (d, 1H), 2.75 (t, 1H), 1.73 (q, 1H), 1.51 (q, 1H), 1.35~ 1.18 (m, 7H), 1.02 (q, 2H), 0.91 (t, 3H).

取0.5g 化合物B7 (1.26 mmol)、0.61g 碳酸銫(1.89 mmol)、28.8mg Pd 2(dba) 3(0.031mmol)及33.9mg DPEPhos(0.063mmol,  (2-二苯基膦苯基)醚)於反應瓶,然後把氣體置換成氮氣、加入5mL無水甲苯,在100°C油浴下反應20小時。待反應液冷卻後,將反應液以矽藻土短管柱過濾、減壓濃縮,接著把濃縮液以柱層析純化,可得到產物C7 0.3g。 Take 0.5g compound B7 (1.26 mmol), 0.61g cesium carbonate (1.89 mmol), 28.8mg Pd 2 (dba) 3 (0.031mmol) and 33.9mg DPEPhos (0.063mmol, (2-diphenylphosphine phenyl) ether ) in the reaction flask, then the gas was replaced with nitrogen, 5 mL of anhydrous toluene was added, and the reaction was carried out at 100° C. in an oil bath for 20 hours. After the reaction solution was cooled, the reaction solution was filtered through a diatomaceous earth short column, concentrated under reduced pressure, and then the concentrated solution was purified by column chromatography to obtain 0.3 g of product C7.

1H-NMR(500MHz, CDCl 3, ppm):7.98 (d, 1H)、7.15 (d, 1H)、 2.88~2.8 (m, 3H)、2.58 (d, 1H)、1.68~1.56 (m, 2H)、1.35~1.18 (m, 5H)、0.88 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.98 (d, 1H), 7.15 (d, 1H), 2.88~2.8 (m, 3H), 2.58 (d, 1H), 1.68~1.56 (m, 2H ), 1.35~1.18 (m, 5H), 0.88 (t, 3H).

取0.5g化合物C7 (1.58 mmol)溶解在10ml THF中,將反應瓶降溫至-78 °C後加入1.11ml 含1.5M n-丁基鋰(1.66 mmol)的丁烷,之後由-78 °C升溫至0℃反應30分鐘。接著在-78°C下加入0.17g 硼酸三甲酯 (1.32 mmol)後,將溫度升至室溫反應1小時。之後加入1ml 醋酸以及0.2ml 30% H 2O 2,接著繼續攪拌至隔日。反應液用乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將得到的濃縮液進行柱層析,可得到產物D7 0.39g。 Get 0.5g of compound C7 (1.58 mmol) and dissolve in 10ml THF, add 1.11ml of butane containing 1.5M n-butyllithium (1.66 mmol) after the reaction bottle is cooled to -78 ° C, then from -78 ° C Raise the temperature to 0°C for 30 minutes. Then, after adding 0.17 g of trimethyl borate (1.32 mmol) at -78 ° C, the temperature was raised to room temperature for 1 hour. After that, 1 ml of acetic acid and 0.2 ml of 30% H 2 O 2 were added, and the stirring was continued until the next day. The reaction solution was extracted with ethyl acetate and water, and the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The obtained concentrate was subjected to column chromatography to obtain 0.39 g of product D7.

1H-NMR(500MHz, CDCl 3, ppm):8.9 (s, 1H)、7.20  (s, 1H)、2.8~2.81 (m, 3H)、2.62 (d, 1H)、1.70~1.58 (m, 2H)、1.33~1.20 (m, 5H)、0.89 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 8.9 (s, 1H), 7.20 (s, 1H), 2.8~2.81 (m, 3H), 2.62 (d, 1H), 1.70~1.58 (m, 2H ), 1.33~1.20 (m, 5H), 0.89 (t, 3H).

取0.5g化合物D7 (1.50 mmol)、0.196g 溴乙烷 (1.80 mmol)及8mL THF於反應瓶,然後再滴入0.23g三乙胺(2.25 mmol),最後加熱回流反應3小時。待反應液降溫後以乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。接著將濃縮物進行柱層析,可得到產物E7 0.47g。 Take 0.5 g of compound D7 (1.50 mmol), 0.196 g of bromoethane (1.80 mmol) and 8 mL of THF in a reaction flask, then add 0.23 g of triethylamine (2.25 mmol) dropwise, and finally heat to reflux for 3 hours. After the reaction solution cooled down, it was extracted with ethyl acetate and water, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. Then the concentrate was subjected to column chromatography to obtain 0.47 g of product E7.

製備得到的化合物E7進行質譜、核磁共振譜測試,測試得到的數據如下。根據測試結果,化合物E7為LSP(TF)-3-O2所示結構。The prepared compound E7 was tested by mass spectrometry and nuclear magnetic resonance spectrum, and the data obtained from the test are as follows. According to the test results, the compound E7 has the structure shown in LSP(TF)-3-O2.

MS(EI, m/z): 272, 315, 360。MS (EI, m/z): 272, 315, 360.

1H-NMR(500MHz, CDCl 3, ppm):7.41 (s, 1H)、4.06 (q, 2H)、 2.8~2.82 (m, 3H)、2.62 (d, 1H)、1.69~1.58 (m, 2H)、1.33~1.20 (m, 8H)、0.88 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.41 (s, 1H), 4.06 (q, 2H), 2.8~2.82 (m, 3H), 2.62 (d, 1H), 1.69~1.58 (m, 2H ), 1.33~1.20 (m, 8H), 0.88 (t, 3H).

13C-NMR(500MHz, CDCl 3, ppm):142、141.7、140.4、134.1、131.7、115.4、113.9、108.6、64.6、38.8、34.6、32.3、27.5、22.6、20.5、14.8、14.2。 13 C-NMR (500 MHz, CDCl 3 , ppm): 142, 141.7, 140.4, 134.1, 131.7, 115.4, 113.9, 108.6, 64.6, 38.8, 34.6, 32.3, 27.5, 22.6, 20.5, 14.8, 14.2.

實施例6Example 6

LSP[T,T]-3-O2

Figure 02_image334
LSP[T,T]-3-O2
Figure 02_image334

合成路線:

Figure 02_image336
synthetic route:
Figure 02_image336

取1.0g 3-丙基環己-1-酮 (7.14 mmol)、1.42g 1-溴-2-碘-3,4-雙 (三氟甲基)苯(3.39 mmol)、2.33g 碳酸銫(7.14 mmol)、73mg Pd 2(dba) 3(0.08 mmol)以及14.8mg Xantphos(0.16 mmol, 4,5-雙二苯基膦-9,9-二甲基氧雜蒽)於反應瓶中,並且將氣體置換成氮氣。接著加入15ml 無水二噁烷進行攪拌,然後加熱至90℃、反應24小時。等待溫度回到室溫後,將反應液以乙酸乙酯以及水進行萃取、收集有機層,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物A8 1.08g。 Take 1.0 g of 3-propylcyclohexan-1-one (7.14 mmol), 1.42 g of 1-bromo-2-iodo-3,4-bis(trifluoromethyl)benzene (3.39 mmol), 2.33 g of cesium carbonate ( 7.14 mmol), 73mg Pd 2 (dba) 3 (0.08 mmol) and 14.8mg Xantphos (0.16 mmol, 4,5-bisdiphenylphosphine-9,9-dimethylxanthene) in the reaction flask, and The gas was replaced with nitrogen. Next, 15 ml of anhydrous dioxane was added and stirred, then heated to 90° C., and reacted for 24 hours. After waiting for the temperature to return to room temperature, the reaction solution was extracted with ethyl acetate and water, and the organic layer was collected. After that, the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 1.08 g of product A8.

1H-NMR(500MHz, CDCl 3, ppm):7.51 (d, 1H)、7.30 (d, 1H)、3.52 (t, 1H)、2.32~2.21 (m, 2H)、2.05~1.96 (m, 2H)、1.73 (m, 2H)、1.51 (q, 1H)、1.32 (q, 2H)、1.21 (q, 2H)、0.90 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.51 (d, 1H), 7.30 (d, 1H), 3.52 (t, 1H), 2.32~2.21 (m, 2H), 2.05~1.96 (m, 2H ), 1.73 (m, 2H), 1.51 (q, 1H), 1.32 (q, 2H), 1.21 (q, 2H), 0.90 (t, 3H).

取0.5g化合物A8 (1.16 mmol)及64.4mg 五硫化二磷(0.29 mmol)於反應瓶內,之後將氣體置換成氮氣,加入8mL無水甲苯、室溫下攪拌30分鐘。接著再加入0.32g 六甲基二矽氧烷(1.97 mmol),移至90°C油浴下攪拌24小時。待反應液冷卻後,將反應液以矽膠短管柱過濾,接著把溶液減壓濃縮,可得到產物B8 0.36g。Take 0.5 g of compound A8 (1.16 mmol) and 64.4 mg of phosphorus pentasulfide (0.29 mmol) in a reaction flask, then replace the gas with nitrogen, add 8 mL of anhydrous toluene, and stir at room temperature for 30 minutes. Next, 0.32 g of hexamethyldisiloxane (1.97 mmol) was added, and the mixture was moved to 90° C. in an oil bath and stirred for 24 hours. After the reaction solution was cooled, the reaction solution was filtered with a short silica gel column, and then the solution was concentrated under reduced pressure to obtain 0.36 g of product B8.

1H-NMR(500MHz, CDCl 3, ppm):7.49 (d, 1H)、7.29 (d, 1H)、2.72 (t, 1H)、1.71 (q, 1H)、1.55 (q, 1H)、1.32~1.18 (m, 7H)、1.04 (m, 2H)、0.89 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.49 (d, 1H), 7.29 (d, 1H), 2.72 (t, 1H), 1.71 (q, 1H), 1.55 (q, 1H), 1.32~ 1.18 (m, 7H), 1.04 (m, 2H), 0.89 (t, 3H).

取0.5g 化合物B8 (1.12 mmol)、0.55g 碳酸銫(1.68 mmol)、25.6mg Pd 2(dba) 3(0.028mmol)及30.2mg DPEphos(0.056 mmol,(2-二苯基膦苯基)醚)於反應瓶,然後把氣體置換成氮氣、加入5mL無水甲苯,在100°C油浴下反應20小時。待反應液冷卻後,將反應液以矽藻土短管柱過濾、減壓濃縮,接著把濃縮液以柱層析純化,可得到產物C8 0.24g。 Take 0.5g compound B8 (1.12 mmol), 0.55 g cesium carbonate (1.68 mmol), 25.6 mg Pd 2 (dba) 3 (0.028 mmol) and 30.2 mg DPEphos (0.056 mmol, (2-diphenylphosphine phenyl) ether ) in the reaction flask, then the gas was replaced with nitrogen, 5 mL of anhydrous toluene was added, and the reaction was carried out at 100° C. in an oil bath for 20 hours. After the reaction solution was cooled, the reaction solution was filtered through a diatomaceous earth short column, concentrated under reduced pressure, and then the concentrated solution was purified by column chromatography to obtain 0.24 g of the product C8.

1H-NMR(500MHz, CDCl 3, ppm):7.76 (d, 1H)、7.51 (d, 1H)、2.90~2.79 (m, 3H)、2.65 (d, 1H)、1.68~1.56 (m, 2H)、1.33~1.20 (m, 5H)、0.91 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.76 (d, 1H), 7.51 (d, 1H), 2.90~2.79 (m, 3H), 2.65 (d, 1H), 1.68~1.56 (m, 2H ), 1.33~1.20 (m, 5H), 0.91 (t, 3H).

取0.5g化合物C8 (1.36 mmol)溶解在10ml THF中,將反應瓶降溫至-78 °C後加入0.95ml 含1.5M n-丁基鋰(1.43 mmol)的己烷,之後由-78°C升溫至0℃反應30分鐘。接著在-78°C下加入0.16g 硼酸三甲酯 (1.5 mmol)後,將溫度回到室溫反應1小時。之後加入1ml 醋酸以及0.15ml 30% H 2O 2,接著繼續攪拌至隔日。反應液用乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將得到的濃縮液進行柱層析,可得到產物D8 0.43g。 Get 0.5g of compound C8 (1.36 mmol) and dissolve it in 10ml THF, add 0.95ml of hexane containing 1.5M n-butyllithium (1.43 mmol) after the reaction bottle is cooled to -78 ° C, then from -78 ° C Raise the temperature to 0°C for 30 minutes. Then, after adding 0.16 g of trimethyl borate (1.5 mmol) at -78° C., the temperature was returned to room temperature for 1 hour. After that, 1 ml of acetic acid and 0.15 ml of 30% H 2 O 2 were added, and the stirring was continued until the next day. The reaction solution was extracted with ethyl acetate and water, and the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The obtained concentrate was subjected to column chromatography to obtain 0.43 g of product D8.

1H-NMR(500MHz, CDCl 3, ppm):9.69 (br, 1H)、7.21  (s, 1H)、2.91~2.80 (m, 3H)、2.63 (d, 1H)、1.68~1.58 (m, 2H)、1.35~1.19 (m, 5H)、0.91 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 9.69 (br, 1H), 7.21 (s, 1H), 2.91~2.80 (m, 3H), 2.63 (d, 1H), 1.68~1.58 (m, 2H ), 1.35~1.19 (m, 5H), 0.91 (t, 3H).

取0.5g化合物D8 (1.31 mmol)、0.17g 溴乙烷 (1.57 mmol)及8mL THF於反應瓶,然後再滴入0.20g 三乙胺 (1.97 mmol) ,最後加熱回流反應3小時。待反應液降溫後以乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。接著將濃縮物進行柱層析,可得到產物E8 0.43g。 Take 0.5 g of compound D8 (1.31 mmol), 0.17 g of bromoethane (1.57 mmol) and 8 mL of THF in a reaction flask, then add 0.20 g of triethylamine (1.97 mmol) dropwise, and finally heat to reflux for 3 hours. After the reaction solution cooled down, it was extracted with ethyl acetate and water, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. Then the concentrate was subjected to column chromatography to obtain 0.43 g of product E8.

製備得到的化合物E8進行質譜、核磁共振譜測試,測試得到的數據如下。根據測試結果,化合物E8為LSP(TT)-3-O2所示結構。The prepared compound E8 was subjected to mass spectrometry and nuclear magnetic resonance spectrometry tests, and the data obtained from the tests are as follows. According to the test results, the compound E8 has the structure shown in LSP(TT)-3-O2.

MS(EI, m/z): 322, 381 ,410。MS (EI, m/z): 322,381,410.

1H-NMR(500MHz, CDCl 3, ppm): 7.35 (s, 1H)、4.8 (q, 2H)、2.8~2.83 (m, 3H)、2.61 (d, 1H)、1.69~1.57 (m, 2H)、1.33~1.20 (m, 8H)、0.89 (t, 3H) 。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.35 (s, 1H), 4.8 (q, 2H), 2.8~2.83 (m, 3H), 2.61 (d, 1H), 1.69~1.57 (m, 2H ), 1.33~1.20 (m, 8H), 0.89 (t, 3H).

13C-NMR(500MHz, CDCl 3, ppm):151.8、143.8、131.5、130.4、123.7、119.7、116.1、109.5、107.3、64.9、38.8、35.8、31.5、27.5、21.6、20.5、14.8、13.9。 13 C-NMR (500 MHz, CDCl 3 , ppm): 151.8, 143.8, 131.5, 130.4, 123.7, 119.7, 116.1, 109.5, 107.3, 64.9, 38.8, 35.8, 31.5, 27.5, 21.6, 20.5, 14.8, 13.9.

實施例7Example 7

CLOY-3-O2

Figure 02_image338
CLOY-3-O2
Figure 02_image338

合成路線:

Figure 02_image340
synthetic route:
Figure 02_image340

取1.0g 4'-丙基-[1,1'-二(環己烷)]-3-酮(4.5 mmol)、0.68g 1-溴-4-氟-2-碘-3-(三氟甲基)苯(2.14 mmol) 、1.46g 碳酸銫 (4.49 mmol)、 49mg Pd 2(dba) 3(0.08 mmol)以及62mg Xantphos (0.11 mmol, 4,5-雙二苯基膦-9,9-二甲基氧雜蒽)於反應瓶中,並且將氣體置換成氮氣。接著加入15ml 無水二噁烷進行攪拌,然後加熱至90℃、反應24小時。等待溫度回到室溫後,將反應液以乙酸乙酯以及水進行萃取、收集有機層,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物A9 0.64g。 Take 1.0g 4'-propyl-[1,1'-di(cyclohexane)]-3-one (4.5 mmol), 0.68g 1-bromo-4-fluoro-2-iodo-3-(trifluoro Methyl)benzene (2.14 mmol), 1.46g cesium carbonate (4.49 mmol), 49mg Pd 2 (dba) 3 (0.08 mmol) and 62mg Xantphos (0.11 mmol, 4,5-bisdiphenylphosphine-9,9- dimethylxanthene) in the reaction flask, and the gas was replaced with nitrogen. Next, 15 ml of anhydrous dioxane was added and stirred, then heated to 90° C., and reacted for 24 hours. After waiting for the temperature to return to room temperature, the reaction solution was extracted with ethyl acetate and water, and the organic layer was collected. After that, the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.64 g of product A9.

1H-NMR(500MHz, CDCl 3, ppm):7.33 (d, 1H)、7.12  (d, 1H)、3.55 (t, 1H)、2.3~2.22 (m, 2H)、2.08~1.98 (m, 2H)、1.78~1.2 (m, 17H)、0.92 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.33 (d, 1H), 7.12 (d, 1H), 3.55 (t, 1H), 2.3~2.22 (m, 2H), 2.08~1.98 (m, 2H ), 1.78~1.2 (m, 17H), 0.92 (t, 3H).

取0.5g 化合物A9 (1.21 mmol)、0.59g 碳酸銫(1.82 mmol)、22.9mg Pd 2(dba) 3(0.028mmol)及32.6mg DPEphos(0.061 mmol,(2-二苯基膦苯基)醚)於反應瓶,然後把氣體置換成氮氣、加入5mL無水甲苯,在100 °C油浴下反應20小時。待反應液冷卻後,將反應液以矽藻土短管柱過濾、減壓濃縮,接著把濃縮液以柱層析純化,可得到產物B9 0.34g。 Take 0.5g compound A9 (1.21 mmol), 0.59 g cesium carbonate (1.82 mmol), 22.9 mg Pd 2 (dba) 3 (0.028 mmol) and 32.6 mg DPEphos (0.061 mmol, (2-diphenylphosphine phenyl) ether ) in the reaction flask, then replace the gas with nitrogen, add 5mL of anhydrous toluene, and react for 20 hours at 100°C in an oil bath. After the reaction solution was cooled, the reaction solution was filtered through a diatomaceous earth short column, concentrated under reduced pressure, and then the concentrated solution was purified by column chromatography to obtain 0.34 g of product B9.

1H-NMR(500MHz, CDCl 3, ppm):7.38 (d, 1H)、6.82 (d, 1H)、2.87~2.75 (q, 2H)、2.46 (d, 1H)、2.30 (d, 1H)、1.66~1.21 (m, 17H)、0.91 (t, 3H) 。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.38 (d, 1H), 6.82 (d, 1H), 2.87~2.75 (q, 2H), 2.46 (d, 1H), 2.30 (d, 1H), 1.66~1.21 (m, 17H), 0.91 (t, 3H).

0.5g化合物B9 (1.50 mmol)溶解在10ml THF中,將反應瓶降溫至-78 °C後加入1.05ml 1.5M n-丁基鋰 in 己烷 (1.58 mmol),之後由-78 °C升溫至0℃反應30分鐘。接著在-78°C下加入0.17g 硼酸三甲酯 (1.65 mmol)後,將溫度回到室溫反應1小時。之後加入1ml 醋酸以及0.17ml 30% H 2O 2,接著繼續攪拌至隔日。反應液用乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將得到的濃縮液進行柱層析,可得到產物C9 0.46g。 0.5g compound B9 (1.50 mmol) was dissolved in 10ml THF, and the reaction flask was cooled to -78 °C, and 1.05ml of 1.5M n-butyl lithium in hexane (1.58 mmol) was added, and then the temperature was raised from -78 °C to React at 0°C for 30 minutes. Then, after adding 0.17 g of trimethyl borate (1.65 mmol) at -78° C., the temperature was returned to room temperature for 1 hour. After that, 1 ml of acetic acid and 0.17 ml of 30% H 2 O 2 were added, and the stirring was continued until the next day. The reaction solution was extracted with ethyl acetate and water, and the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The obtained concentrate was subjected to column chromatography to obtain 0.46 g of product C9.

1H-NMR(500MHz, CDCl 3, ppm):9.63 (s, 1H)、 7.15 (d, 1H)、 2.87~2.74 (m, 2H)、2.48 (d, 1H)、2.23 (d, 1H)、1.72~1.3 (m, 17H)、0.91 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 9.63 (s, 1H), 7.15 (d, 1H), 2.87~2.74 (m, 2H), 2.48 (d, 1H), 2.23 (d, 1H), 1.72~1.3 (m, 17H), 0.91 (t, 3H).

取0.5g化合物D9 (1.44 mmol)、0.19g 溴乙烷 (1.73 mmol)及8mL THF於反應瓶,然後再滴入0.22g 三乙胺 (2.16 mmol),最後加熱回流反應3小時。待反應液降溫後以乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。接著將濃縮物進行柱層析,可得到產物D9 0.45g。 Take 0.5 g of compound D9 (1.44 mmol), 0.19 g of bromoethane (1.73 mmol) and 8 mL of THF in a reaction flask, then add 0.22 g of triethylamine (2.16 mmol) dropwise, and finally heat to reflux for 3 hours. After the reaction solution cooled down, it was extracted with ethyl acetate and water, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. Then the concentrate was subjected to column chromatography to obtain 0.45 g of product D9.

製備得到的化合物D9進行質譜、核磁共振譜測試,測試得到的數據如下。根據測試結果,化合物為CLOY-3-O2所示結構。The prepared compound D9 was subjected to mass spectrometry and nuclear magnetic resonance spectrometry tests, and the data obtained from the tests are as follows. According to the test results, the compound has the structure shown in CLOY-3-O2.

MS(EI, m/z): 206, 251, 376。MS (EI, m/z): 206, 251, 376.

1H-NMR(500MHz, CDCl 3, ppm):7.33 (s, 1H)、4.13 (q, 2H)、2.90~2.78 (q, 2H)、2.47 (d, 1H)、2.23 (d, 1H)、1.71~1.31 (m, 20H)、0.93 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.33 (s, 1H), 4.13 (q, 2H), 2.90~2.78 (q, 2H), 2.47 (d, 1H), 2.23 (d, 1H), 1.71~1.31 (m, 20H), 0.93 (t, 3H).

13C-NMR(500MHz, CDCl 3, ppm):155.4、150.5、143.5、142.8、129.5、112.1、109.6、93.6、64.6、40.1、37.3、35.8、30.3、29.3、26.8、20.5、17.1、15.1、14.4。 13 C-NMR (500MHz, CDCl 3 , ppm): 155.4, 150.5, 143.5, 142.8, 129.5, 112.1, 109.6, 93.6, 64.6, 40.1, 37.3, 35.8, 30.3, 29.3, 26.8, 20.5, 17.1, 15.1, 14.4 .

實施例8Example 8

CLSY-3-O2

Figure 02_image342
CLSY-3-O2
Figure 02_image342

合成路線:

Figure 02_image344
synthetic route:
Figure 02_image344

取1.0g 4'-丙基-[1,1'-二(環己烷)]-3-酮(2.5 mmol)、0.68g 1-溴-4-氟-2-碘-3-(三氟甲基)苯(2.14 mmol)、1.46g 碳酸銫 (4.49 mmol)、 49mg Pd 2(dba) 3(0.08 mmol)以及62mg Xantphos (0.11 mmol, 4,5-雙二苯基膦-9,9-二甲基氧雜蒽)於反應瓶內,並且將氣體置換成氮氣。接著加入15ml 無水二噁烷進行攪拌,然後加熱至90℃、反應24小時。等待溫度回到室溫後,將反應液以乙酸乙酯以及水進行萃取、收集有機層,之後將有機層以無水MgSO 4除水、減壓濃縮。將濃縮物進行柱層析,可得到產物A10 0.64g。 Take 1.0g 4'-propyl-[1,1'-bis(cyclohexane)]-3-one (2.5 mmol), 0.68g 1-bromo-4-fluoro-2-iodo-3-(trifluoro Methyl)benzene (2.14 mmol), 1.46g cesium carbonate (4.49 mmol), 49mg Pd 2 (dba) 3 (0.08 mmol) and 62mg Xantphos (0.11 mmol, 4,5-bisdiphenylphosphine-9,9- dimethylxanthene) in the reaction flask, and the gas was replaced with nitrogen. Next, 15 ml of anhydrous dioxane was added and stirred, then heated to 90° C., and reacted for 24 hours. After waiting for the temperature to return to room temperature, the reaction solution was extracted with ethyl acetate and water, and the organic layer was collected. After that, the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The concentrate was subjected to column chromatography to obtain 0.64 g of product A10.

1H-NMR(500MHz, CDCl 3, ppm):7.33 (d, 1H)、7.12 (d, 1H)、3.55 (t, 1H)、2.3~2.22 (m, 2H)、2.08~1.98 (m, 2H)、1.78~1.2 (m, 17H)、0.92 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.33 (d, 1H), 7.12 (d, 1H), 3.55 (t, 1H), 2.3~2.22 (m, 2H), 2.08~1.98 (m, 2H ), 1.78~1.2 (m, 17H), 0.92 (t, 3H).

取0.5g化合物A10 (1.21 mmol)及67.2mg 五硫化二磷(0.30 mmol)於反應瓶中,之後將氣體置換成氮氣,加入8mL無水甲苯,室溫下攪拌30分鐘。接著再加入0.33g 六甲基二矽氧烷(2.06 mmol),移至90°C油浴下攪拌24小時。待反應液冷卻後,將反應液以矽膠短管柱過濾,接著把溶液減壓濃縮,可得到產物B10 0.52g。Take 0.5 g of compound A10 (1.21 mmol) and 67.2 mg of phosphorus pentasulfide (0.30 mmol) in a reaction flask, then replace the gas with nitrogen, add 8 mL of anhydrous toluene, and stir at room temperature for 30 minutes. Next, 0.33 g of hexamethyldisiloxane (2.06 mmol) was added, and the mixture was moved to a 90° C. oil bath and stirred for 24 hours. After the reaction solution was cooled, the reaction solution was filtered through a short silica gel column, and then the solution was concentrated under reduced pressure to obtain 0.52 g of the product B10.

1H-NMR(500MHz, CDCl 3, ppm):7.33 (d, 1H)、7.11 (d, 1H)、2.76 (t, 1H))、1.82~1.05 (m, 21H)、0.91 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.33 (d, 1H), 7.11 (d, 1H), 2.76 (t, 1H)), 1.82~1.05 (m, 21H), 0.91 (t, 3H) .

取0.5g 化合物B10 (1.16 mmol)、0.57g 碳酸銫(1.74 mmol)、29mg Pd 2(dba) 3(0.029mmol)及31.2mg DPEphos(0.058 mmol,(2-二苯基膦苯基)醚)於反應瓶,然後把氣體置換成氮氣、加入5mL無水甲苯,在100 °C油浴下反應20小時。待反應液冷卻後,將反應液以矽藻土短管柱過濾、減壓濃縮,接著把濃縮液以柱層析純化,可得到產物C10 0.27g。 Take 0.5g compound B10 (1.16 mmol), 0.57g cesium carbonate (1.74 mmol), 29 mg Pd 2 (dba) 3 (0.029 mmol) and 31.2 mg DPEphos (0.058 mmol, (2-diphenylphosphine phenyl) ether) In the reaction bottle, then the gas was replaced with nitrogen, 5mL of anhydrous toluene was added, and the reaction was carried out at 100°C in an oil bath for 20 hours. After the reaction solution was cooled, the reaction solution was filtered through a diatomaceous earth short column, concentrated under reduced pressure, and then the concentrated solution was purified by column chromatography to obtain 0.27 g of the product C10.

1H-NMR(500MHz, CDCl 3, ppm):7.82 (d, 1H)、 7.18 (d, 1H)、 2.92~2.81 (m, 3H)、2.58 (d, 1H)、1.66~1.17 (m, 17H)、0.91 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.82 (d, 1H), 7.18 (d, 1H), 2.92~2.81 (m, 3H), 2.58 (d, 1H), 1.66~1.17 (m, 17H ), 0.91 (t, 3H).

取0.5g化合物C10 (1.43 mmol)溶解在10ml THF中,將反應瓶降溫至-78 °C後加入1.0ml 含1.5M n-丁基鋰(1.50 mmol)的己烷,之後由-78 °C升溫至0℃反應30分鐘。接著在-78°C下加入0.16g 硼酸三甲酯 (1.57 mmol)後,將溫度回到室溫反應1小時。之後加入1ml 醋酸以及0.18ml 30% H 2O 2,接著繼續攪拌至隔日。反應液用乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。將得到的濃縮液進行柱層析,可得到產物D10 0.4g。 Get 0.5g of compound C10 (1.43 mmol) and dissolve in 10ml THF, add 1.0ml of hexane containing 1.5M n-butyllithium (1.50 mmol) after the reaction bottle is cooled to -78 °C, then from -78 °C Raise the temperature to 0°C for 30 minutes. Then, after adding 0.16 g of trimethyl borate (1.57 mmol) at -78° C., the temperature was returned to room temperature for 1 hour. After that, 1 ml of acetic acid and 0.18 ml of 30% H 2 O 2 were added, and the stirring was continued until the next day. The reaction solution was extracted with ethyl acetate and water, and the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. The obtained concentrate was subjected to column chromatography to obtain 0.4 g of product D10.

1H-NMR(500MHz, CDCl 3, ppm): 9.23 (s, 1H)、7.15 (s, 1H)、2.92~2.83  (m, 3H)、2.60 (d, 1H)、1.66~1.17 (m, 17H)、0.92 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 9.23 (s, 1H), 7.15 (s, 1H), 2.92~2.83 (m, 3H), 2.60 (d, 1H), 1.66~1.17 (m, 17H ), 0.92 (t, 3H).

取0.5g化合物D10 (1.37 mmol)、0.18g 溴乙烷(1.65 mmol)及8mL THF於反應瓶,然後再滴入0.21g 三乙胺 (2.06 mmol),最後加熱回流反應3小時。待反應液降溫後以乙酸乙酯以及水進行萃取,之後將有機層以無水MgSO 4除水、減壓濃縮。接著將濃縮物進行柱層析,可得到產物E10 0.43g。 Take 0.5 g of compound D10 (1.37 mmol), 0.18 g of bromoethane (1.65 mmol) and 8 mL of THF in a reaction flask, then add 0.21 g of triethylamine (2.06 mmol) dropwise, and finally heat to reflux for 3 hours. After the reaction solution cooled down, it was extracted with ethyl acetate and water, and then the organic layer was dehydrated with anhydrous MgSO 4 and concentrated under reduced pressure. Then the concentrate was subjected to column chromatography to obtain 0.43 g of product E10.

製備得到的化合物E10進行質譜、核磁共振譜測試,測試得到的數據如下。根據測試結果,化合物為CLSY-3-O2所示結構。The prepared compound E10 was tested by mass spectrometry and nuclear magnetic resonance spectrum, and the data obtained from the tests are as follows. According to the test results, the compound has the structure shown in CLSY-3-O2.

MS(EI, m/z): 222, 349, 392。MS (EI, m/z): 222, 349, 392.

1H-NMR(500MHz, CDCl 3, ppm): 7.18 (s, 1H)、4.13 (q, 2H)、 2.92~2.81 (m, 3H)、2.63 (d, 1H)、1.66~1.17 (m, 20H)、0.90 (t, 3H)。 1 H-NMR (500MHz, CDCl 3 , ppm): 7.18 (s, 1H), 4.13 (q, 2H), 2.92~2.81 (m, 3H), 2.63 (d, 1H), 1.66~1.17 (m, 20H ), 0.90 (t, 3H).

13C-NMR(500MHz, CDCl 3, ppm):145.5、143.3、141.8、135.4、131.5、129.6、121.7、100.9、64.6、42.6、39.7、37.1、30.9、29.3、26.8、25.3、22.6、20.5、15.5、13.8。 13 C-NMR (500MHz, CDCl 3 , ppm): 145.5, 143.3, 141.8, 135.4, 131.5, 129.6, 121.7, 100.9, 64.6, 42.6, 39.7, 37.1, 30.9, 29.3, 26.8, 25.3, 22.6, 20.5, 15.5 , 13.8.

對於下述的表1所示的前述實施例及對比例的各化合物單體,將其與下述的母體液晶以重量百分比計按照10%化合物單體與90%母體液晶的比例混合相容後,在下述的條件下測量T NI、Δn、Δε、K 11、K 33、G1,然後採用外插法計算得到單體的T NI、Δn、Δε、K 11、K 33、G1,得到的單體的各物理性能結果示於後述的表2中。 For each compound monomer of the preceding examples and comparative examples shown in the following Table 1, it is mixed and compatible with the following mother liquid crystal by weight percentage according to the ratio of 10% compound monomer and 90% mother liquid crystal , measure T NI , Δn, Δε, K 11 , K 33 , and G1 under the following conditions, and then use extrapolation to calculate the T NI , Δn, Δε, K 11 , K 33 , and G1 of the monomer. The results of various physical properties of the body are shown in Table 2 described later.

前述的母體液晶中各組分及其質量百分含量如下: CCG-2-F 10% CCP-V-1 20% CCP-V2-1 20% CPU-3-F 20% CP-3-O2 15% CP-3-O1 15% Each component and its mass percent content in the aforementioned parent liquid crystal are as follows: CCG-2-F 10% CCP-V-1 20% CCP-V2-1 20% CPU-3-F 20% CP-3-O2 15% CP-3-O1 15%

根據這些測試結果計算得到的響應指標值G1/(K 11*△n*△n)、G1/(K 33*△n*△n)示於後述的表3中,在VA(vertical alignment,垂直取向)或者PS-VA(Polymer stabilized vertical alignment,聚合物穩定垂直取向)模式下,液晶介質的響應時間與指標G1/(K 33*△n*△n)相關,而在FFS(Fringe Field Switching,邊緣場開關)、IPS(In-Plane Switching,平面轉換)、PS-FFS(Polymer stabilized Fringe Field Switching,聚合物穩定邊緣場開關)、PS-IPS(Polymer stabilized In-Plane Switching,聚合物穩定平面轉換)等模式下,液晶介質的響應時間與響應指標值G1/(K 11*△n*△n)相關。前述的響應指標值越小,表明響應時間越快。 The response index values G1/(K 11 *△n*△n) and G1/(K 33 *△n*△n) calculated according to these test results are shown in Table 3 below. In VA (vertical alignment, vertical orientation) or PS-VA (Polymer stabilized vertical alignment, polymer stabilized vertical alignment) mode, the response time of the liquid crystal medium is related to the index G1/(K 33 *△n*△n), while in FFS (Fringe Field Switching, fringe field switch), IPS (In-Plane Switching, plane switching), PS-FFS (Polymer stabilized Fringe Field Switching, polymer stabilized fringe field switch), PS-IPS (Polymer stabilized In-Plane Switching, polymer stabilized plane switching ) and other modes, the response time of the liquid crystal medium is related to the response index value G1/(K 11 *△n*△n). The smaller the aforementioned response index value, the faster the response time.

T NI代表液晶單體由向列相相變至澄清相之溫度,其溫度通過MP-90設備測量; T NI represents the temperature at which the liquid crystal monomer changes from a nematic phase to a clear phase, and its temperature is measured by MP-90 equipment;

Δn表示光學各向異性,Δn=n e-n o,其中,n o為尋常光的折射率,n e為非尋常光的折射率,測試條件:589 nm、25±0.2℃。 Δn represents optical anisotropy, Δn=n e -n o , where n o is the refractive index of ordinary light, and ne is the refractive index of extraordinary light. Test conditions: 589 nm, 25±0.2°C.

Δε表示介電各向異性,Δε=ε ,其中,ε 為平行于分子軸的介電常數,ε 為垂直于分子軸的介電常數,測試條件:25℃、INSTEC:ALCT-IR1、18微米垂直盒; Δε represents dielectric anisotropy, Δε=ε , where ε is the dielectric constant parallel to the molecular axis, ε is the dielectric constant perpendicular to the molecular axis, test conditions: 25°C, INSTEC: ALCT-IR1, 18 micron vertical cell;

K 11為扭曲彈性常數,K 33為展曲彈性常數,測試條件為:25℃、INSTEC:ALCT-IR1、18微米垂直盒。 K 11 is the torsional elastic constant, K 33 is the splay elastic constant, and the test conditions are: 25°C, INSTEC: ALCT-IR1, 18 micron vertical box.

Gamma1(mPa.s) 為旋轉粘滯係數,簡寫為“G1”,測試條件為:25℃、INSTEC:ALCT-IR1、18微米垂直盒。Gamma1(mPa.s) is the coefficient of rotational viscosity, abbreviated as "G1", and the test conditions are: 25°C, INSTEC: ALCT-IR1, 18 micron vertical box.

表1:實施例及對比例的各化合物 對比例 1 LY-3-O2

Figure 02_image346
對比例 2 CLY-3-O2
Figure 02_image348
實施例1 (IA-1) LOY-3-O2
Figure 02_image314
實施例2 (Ia-1) LSY-3-O2
Figure 02_image318
實施例3 (Ib-1) LSP[F,OT]-3-O2
Figure 02_image322
實施例4 (Id-1) LSP[OT,OT]-3-O2
Figure 02_image326
實施例5 (If-1) LSP[T,F]-3-O2
Figure 02_image330
實施例6 (Ig-1) LSP[T,T]-3-O2
Figure 02_image334
實施例7 (IH-1) CLOY-3-O2
Figure 02_image338
實施例8 (Ih-1) CLSY-3-O2
Figure 02_image342
Table 1: each compound of embodiment and comparative example Comparative example 1 LY-3-O2
Figure 02_image346
Comparative example 2 CLY-3-O2
Figure 02_image348
Example 1 (IA-1) LOY-3-O2
Figure 02_image314
Example 2 (Ia-1) LSY-3-O2
Figure 02_image318
Example 3 (Ib-1) LSP[F,OT]-3-O2
Figure 02_image322
Example 4 (Id-1) LSP[OT,OT]-3-O2
Figure 02_image326
Example 5 (If-1) LSP[T,F]-3-O2
Figure 02_image330
Example 6 (Ig-1) LSP[T,T]-3-O2
Figure 02_image334
Example 7 (IH-1) CLOY-3-O2
Figure 02_image338
Example 8 (Ih-1) CLSY-3-O2
Figure 02_image342

表2:實施例及對比例的各化合物的物理性能結果 物理特性(25℃) 清亮點T NI(℃) 折光率(

Figure 02_image358
n) 介電常數(
Figure 02_image003
)
彈性係數K 11(pN) 彈性係數K 33(pN) 旋轉粘滯係數 G1(mPa.s) 對比例1 -5.8 0.0895 -6.0 1.8 3.2 49.3 對比例2 172.5 0.1470 -6.5 34.1 38.0 1025.2 實施例1 12.2 0.1195 -5.9 5.2 6.9 66.2 實施例2 52.2 0.1177 -6.0 12.7 15.2 129.2 實施例3 51.2 0.1077 -9.0 14.7 17.2 103.3 實施例4 55.0 0.1027 -11.0 15.7 18.2 90.4 實施例5 42.2 0.0977 -11.0 11.7 14.2 64.6 實施例6 37.2 0.0927 -13.0 10.68 13.23 51.7 實施例7 192.5 0.1770 -6.4 38.8 44.1 1245.6 實施例8 232.5 0.1970 -6.4 46.3 52.4 1532.5 Table 2: The physical property result of each compound of embodiment and comparative example Physical Properties (25℃) Clearing point T NI (℃) Refractive index (
Figure 02_image358
n)
Dielectric constant (
Figure 02_image003
)
Elastic coefficient K 11 (pN) Elastic coefficient K 33 (pN) Coefficient of rotational viscosity G1(mPa.s)
Comparative example 1 -5.8 0.0895 -6.0 1.8 3.2 49.3 Comparative example 2 172.5 0.1470 -6.5 34.1 38.0 1025.2 Example 1 12.2 0.1195 -5.9 5.2 6.9 66.2 Example 2 52.2 0.1177 -6.0 12.7 15.2 129.2 Example 3 51.2 0.1077 -9.0 14.7 17.2 103.3 Example 4 55.0 0.1027 -11.0 15.7 18.2 90.4 Example 5 42.2 0.0977 -11.0 11.7 14.2 64.6 Example 6 37.2 0.0927 -13.0 10.68 13.23 51.7 Example 7 192.5 0.1770 -6.4 38.8 44.1 1245.6 Example 8 232.5 0.1970 -6.4 46.3 52.4 1532.5

表3:實施例及對比例的各化合物的響應指標值 物理特性(25℃) G1/(K 11*△n*△n) G1/(K 33*△n*△n) 對比例1 3398.3 1946.5 對比例2 1392.5 1249.1 實施例1 893.3 672.0 實施例2 735.3 612.2 實施例3 606.9 517.1 實施例4 546.7 470.3 實施例5 579.3 475.5 實施例6 563.0 454.5 實施例7 1024.4 900.9 實施例8 852.9 753.3 Table 3: The response index value of each compound of embodiment and comparative example Physical Properties (25℃) G1/(K 11 *△n*△n) G1/(K 33 *△n*△n) Comparative example 1 3398.3 1946.5 Comparative example 2 1392.5 1249.1 Example 1 893.3 672.0 Example 2 735.3 612.2 Example 3 606.9 517.1 Example 4 546.7 470.3 Example 5 579.3 475.5 Example 6 563.0 454.5 Example 7 1024.4 900.9 Example 8 852.9 753.3

通過表3中實施例1~8以及對比例1~2的響應指標指的對比可以看出,實施例1~8的液晶化合物的響應指標值G1/(K 11*△n*△n)、G1/(K 33*△n*△n)相對於對比例降低。 It can be seen from the comparison of the response indicators of Examples 1-8 and Comparative Examples 1-2 in Table 3 that the response indicators of the liquid crystal compounds of Examples 1-8 are G1/(K 11 *Δn*Δn), G1/(K 33 *Δn*Δn) decreased relative to the comparative example.

本發明可用其他的不違背本發明的精神或主要特徵的具體形式來概述。因此,無論從哪一點來看,本發明的上述實施方案都只能認為是對本發明的說明而不能限制本發明,權利要求書指出了本發明的範圍,而上述的說明並未指出本發明的範圍,因此,在與本發明的權利要求書相當的含義和範圍內的任何改變,都應認為是包括在本發明的權利要求書的範圍內。The present invention may be embodied in other specific forms without departing from the spirit or main characteristics of the invention. Therefore, no matter from which point of view, the above-mentioned embodiments of the present invention can only be regarded as descriptions of the present invention and cannot limit the present invention, and the claims have pointed out the scope of the present invention, and the above description does not point out the scope of the present invention. Therefore, any changes within the meaning and scope equivalent to the claims of the present invention should be considered to be included in the scope of the claims of the present invention.

圖1為本發明的實施例1中製備的化合物LOY-3-O2溶於CDCl 31H核磁共振光譜圖。 圖2為本發明的實施例1中製備的化合物LOY-3-O2溶於CDCl 313C核磁共振光譜圖。 Fig. 1 is the 1 H nuclear magnetic resonance spectrum of the compound LOY-3-O2 prepared in Example 1 of the present invention dissolved in CDCl 3 . Fig. 2 is a 13 C nuclear magnetic resonance spectrum of the compound LOY-3-O2 prepared in Example 1 of the present invention dissolved in CDCl 3 .

Figure 01_image001
Figure 01_image001

Claims (8)

一種具有負介電各向異性液晶化合物,其具有下述式Ⅰ所示結構:
Figure 03_image001
I 式I中,R 1、R 2各自獨立地表示氫原子、碳原子數為1~8的直鏈烷基、碳原子數為1~8的直鏈烷氧基、碳原子數為2~8的直鏈烯基、或者碳原子數為2~8的直鏈烯氧基,其中一個或兩個不相鄰的-CH 2-任選被-O-取代,任意的H任選被F原子取代; 環A1選自下述的基團組成的組:1,4-亞環己基、環己烯-1,4-二基、1,4-亞苯基、2-氟-1,4-亞苯基、2,3-二氟-1,4-亞苯基、氧雜環己烷-2,5-二基、1,3-二氧雜環己烷-2,5-二基、1-甲基環己烷-1,4-二基、2-甲基環己烷-1,4-二基、2-甲基苯-1,4-二基; Z表示單鍵、-C 2H 2-、-C 2H 4-、-C 2H 2CH 2O-、-OCH 2C 2H 2-、-CH 2O-、-OCH 2-、-C 2H 2CH 2S-、-SCH 2C 2H 2-、-CH 2S-、-SCH 2-、-O-、-S-、-CF 2O-、-OCF 2-、-C≡C-、-OOC-或者-COO-、其中-CH 2O-、-C 2H 2-、-C 2H 4-、-C 2H 2CH 2O-、-OCH 2C 2H 2-中任意H任選被F取代; X表示-O-、-S-、-SO-、-SOO-、-CF 2-、-CO-或者-CH 2-; Y 1、Y 2各自獨立地表示-F-、-CH 2F-、-CHF 2-、-CF 3-、-OCH 2F-、-OCHF 2-或者-OCF 3-; n表示0、1、2或3。
A liquid crystal compound with negative dielectric anisotropy, which has the structure shown in the following formula I:
Figure 03_image001
I In formula I, R 1 and R 2 each independently represent a hydrogen atom, a straight chain alkyl group with 1 to 8 carbon atoms, a straight chain alkoxy group with 1 to 8 carbon atoms, and a straight chain alkoxy group with 2 to 8 carbon atoms. 8 straight-chain alkenyl, or straight-chain alkenyloxy with 2 to 8 carbon atoms, wherein one or two non-adjacent -CH 2 - are optionally substituted by -O-, and any H is optionally substituted by F Atom substitution; ring A1 is selected from the group consisting of the following groups: 1,4-cyclohexylene, cyclohexene-1,4-diyl, 1,4-phenylene, 2-fluoro-1,4 -phenylene, 2,3-difluoro-1,4-phenylene, oxane-2,5-diyl, 1,3-dioxane-2,5-diyl , 1-methylcyclohexane-1,4-diyl, 2-methylcyclohexane-1,4-diyl, 2-methylbenzene-1,4-diyl; Z represents a single bond, - C 2 H 2 -, -C 2 H 4 -, -C 2 H 2 CH 2 O-, -OCH 2 C 2 H 2 -, -CH 2 O-, -OCH 2 -, -C 2 H 2 CH 2 S-, -SCH 2 C 2 H 2 -, -CH 2 S-, -SCH 2 -, -O-, -S-, -CF 2 O-, -OCF 2 -, -C≡C-, -OOC -or -COO-, where any H in -CH 2 O-, -C 2 H 2 -, -C 2 H 4 -, -C 2 H 2 CH 2 O-, -OCH 2 C 2 H 2 - is optional Substituted by F; X represents -O-, -S-, -SO-, -SOO-, -CF 2 -, -CO- or -CH 2 -; Y 1 and Y 2 each independently represent -F-, - CH 2 F-, -CHF 2 -, -CF 3 -, -OCH 2 F-, -OCHF 2- or -OCF 3 -; n represents 0, 1, 2 or 3.
如請求項1所述的具有負介電各向異性的液晶化合物,其中,R 1表示氫原子、碳原子數為1~5的直鏈烷基、碳原子數為1~5的直鏈烷氧基、碳原子數為2~5的直鏈烯基、或者碳原子數為2~5的直鏈烯氧基,其中一個或兩個不相鄰的-CH 2-任選被-O-所取代,任意H任選被F原子取代。 The liquid crystal compound with negative dielectric anisotropy as described in claim item 1, wherein, R 1 represents a hydrogen atom, a straight-chain alkyl group with 1 to 5 carbon atoms, and a straight-chain alkyl group with 1 to 5 carbon atoms Oxygen, straight-chain alkenyl with 2 to 5 carbon atoms, or straight-chain alkenyloxy with 2 to 5 carbon atoms, in which one or two non-adjacent -CH 2 - are optionally replaced by -O- Substituted, any H is optionally substituted by an F atom. 如請求項1或2所述的具有負介電各向異性的液晶化合物,其中,n表示0、1或者2。The liquid crystal compound with negative dielectric anisotropy according to Claim 1 or 2, wherein n represents 0, 1 or 2. 如請求項3所述的具有負介電各向異性的液晶化合物,其中,n表示0或者1。The liquid crystal compound with negative dielectric anisotropy as claimed in claim 3, wherein n represents 0 or 1. 如請求項1所述的具有負介電各向異性的液晶化合物,其為選自下述的式IA~IN、Ia~In所示化合物組成的組,其中R 1、R 2定義與請求項1中相同,
Figure 03_image012
IA
Figure 03_image014
IB
Figure 03_image016
IC
Figure 03_image018
ID
Figure 03_image020
IE
Figure 03_image022
IF
Figure 03_image024
IG
Figure 03_image026
IH
Figure 03_image028
II
Figure 03_image030
IJ
Figure 03_image032
IK
Figure 03_image034
IL
Figure 03_image036
IM
Figure 03_image038
IN
Figure 03_image040
Ia
Figure 03_image042
Ib
Figure 03_image044
Ic
Figure 03_image046
Id
Figure 03_image048
Ie
Figure 03_image050
If
Figure 03_image052
Ig
Figure 03_image054
Ih
Figure 03_image056
Ii
Figure 03_image058
Ij
Figure 03_image060
Ik
Figure 03_image062
Il
Figure 03_image064
Im
Figure 03_image066
In。
The liquid crystal compound with negative dielectric anisotropy as described in claim item 1, which is selected from the group consisting of compounds represented by the following formulas IA~IN, Ia~In, wherein R 1 and R 2 are as defined in the claim item same as in 1,
Figure 03_image012
IA
Figure 03_image014
IB
Figure 03_image016
IC
Figure 03_image018
ID
Figure 03_image020
IE
Figure 03_image022
IF
Figure 03_image024
IG
Figure 03_image026
IH
Figure 03_image028
II
Figure 03_image030
IJ
Figure 03_image032
IK
Figure 03_image034
IL
Figure 03_image036
IM
Figure 03_image038
IN
Figure 03_image040
Ia
Figure 03_image042
Ib
Figure 03_image044
IC
Figure 03_image046
ID
Figure 03_image048
Ie
Figure 03_image050
If
Figure 03_image052
Ig
Figure 03_image054
Ih
Figure 03_image056
II
Figure 03_image058
Ij
Figure 03_image060
Ik
Figure 03_image062
Il
Figure 03_image064
Im
Figure 03_image066
In.
如請求項1所述的具有負介電各向異性的液晶化合物,其係選自下述的式IA-1~IN-4、Ia-1~In-4所示的化合物組成的組,其中,Alkyl各自獨立地表示碳原子數為1~8的直鏈烷基、Alkenyl各自獨立地表示碳原子數為2~8的直鏈烯基,
Figure 03_image068
IA-1
Figure 03_image070
IA-2
Figure 03_image072
IA-3
Figure 03_image074
IA-4
Figure 03_image076
IB-1
Figure 03_image078
IB-2
Figure 03_image080
IB-3
Figure 03_image082
IB-4
Figure 03_image084
IC-1
Figure 03_image086
IC-2
Figure 03_image088
IC-3
Figure 03_image090
IC-4
Figure 03_image092
ID-1
Figure 03_image094
ID-2
Figure 03_image096
ID-3
Figure 03_image098
ID-4
Figure 03_image100
IE-1
Figure 03_image102
IE-2
Figure 03_image104
IE-3
Figure 03_image106
IE-4
Figure 03_image108
IF-1
Figure 03_image110
IF-2
Figure 03_image112
IF-3
Figure 03_image114
IF-4
Figure 03_image116
IG-1
Figure 03_image118
IG-2
Figure 03_image120
IG-3
Figure 03_image122
IG-4
Figure 03_image124
IH-1
Figure 03_image126
IH-2
Figure 03_image128
IH-3
Figure 03_image130
IH-4
Figure 03_image132
II-1
Figure 03_image134
II-2
Figure 03_image136
II-3
Figure 03_image138
II-4
Figure 03_image140
IJ-1
Figure 03_image142
IJ-2
Figure 03_image144
IJ-3
Figure 03_image146
IJ-4
Figure 03_image148
IK-1
Figure 03_image150
IK-2
Figure 03_image152
IK-3
Figure 03_image154
IK-4
Figure 03_image156
IL-1
Figure 03_image158
IL-2
Figure 03_image160
IL-3
Figure 03_image162
IL-4
Figure 03_image164
IM-1
Figure 03_image166
IM-2
Figure 03_image168
IM-3
Figure 03_image170
IM-4
Figure 03_image172
IN-1
Figure 03_image174
IN-2
Figure 03_image176
IN-3
Figure 03_image178
IN-4
Figure 03_image180
Ia-1
Figure 03_image182
Ia-2
Figure 03_image184
Ia-3
Figure 03_image186
Ia-4
Figure 03_image188
Ib-1
Figure 03_image190
Ib-2
Figure 03_image192
Ib-3
Figure 03_image194
Ib-4
Figure 03_image196
Ic-1
Figure 03_image198
Ic-2
Figure 03_image200
Ic-3
Figure 03_image202
Ic-4
Figure 03_image204
Id-1
Figure 03_image206
Id-2
Figure 03_image208
Id-3
Figure 03_image210
Id-4
Figure 03_image212
Ie-1
Figure 03_image214
Ie-2
Figure 03_image216
Ie-3
Figure 03_image218
Ie-4
Figure 03_image220
If-1
Figure 03_image222
If-2
Figure 03_image224
If-3
Figure 03_image226
If-4
Figure 03_image228
Ig-1
Figure 03_image230
Ig-2
Figure 03_image232
Ig-3
Figure 03_image234
Ig-4
Figure 03_image236
Ih-1
Figure 03_image238
Ih-2
Figure 03_image240
Ih-3
Figure 03_image242
Ih-4
Figure 03_image244
Ii-1
Figure 03_image246
Ii-2
Figure 03_image248
Ii-3
Figure 03_image250
Ii-4
Figure 03_image252
Ij-1
Figure 03_image254
Ij-2
Figure 03_image256
Ij-3
Figure 03_image258
Ij-4
Figure 03_image260
Ik-1
Figure 03_image262
Ik-2
Figure 03_image264
Ik-3
Figure 03_image266
Ik-4
Figure 03_image268
Il-1
Figure 03_image270
Il-2
Figure 03_image272
Il-3
Figure 03_image274
Il-4
Figure 03_image276
Im-1
Figure 03_image278
Im-2
Figure 03_image280
Im-3
Figure 03_image282
Im-4
Figure 03_image284
In-1
Figure 03_image286
In-2
Figure 03_image288
In-3
Figure 03_image290
In-4。
The liquid crystal compound with negative dielectric anisotropy as described in claim 1, which is selected from the group consisting of compounds represented by the following formulas IA-1~IN-4, Ia-1~In-4, wherein , Alkyl each independently represents a straight-chain alkyl group with 1 to 8 carbon atoms, and Alkenyl each independently represents a straight-chain alkenyl group with 2 to 8 carbon atoms,
Figure 03_image068
IA-1
Figure 03_image070
IA-2
Figure 03_image072
IA-3
Figure 03_image074
IA-4
Figure 03_image076
IB-1
Figure 03_image078
IB-2
Figure 03_image080
IB-3
Figure 03_image082
IB-4
Figure 03_image084
IC-1
Figure 03_image086
IC-2
Figure 03_image088
IC-3
Figure 03_image090
IC-4
Figure 03_image092
ID-1
Figure 03_image094
ID-2
Figure 03_image096
ID-3
Figure 03_image098
ID-4
Figure 03_image100
IE-1
Figure 03_image102
IE-2
Figure 03_image104
IE-3
Figure 03_image106
IE-4
Figure 03_image108
IF-1
Figure 03_image110
IF-2
Figure 03_image112
IF-3
Figure 03_image114
IF-4
Figure 03_image116
IG-1
Figure 03_image118
IG-2
Figure 03_image120
IG-3
Figure 03_image122
IG-4
Figure 03_image124
IH-1
Figure 03_image126
IH-2
Figure 03_image128
IH-3
Figure 03_image130
IH-4
Figure 03_image132
II-1
Figure 03_image134
II-2
Figure 03_image136
II-3
Figure 03_image138
II-4
Figure 03_image140
IJ-1
Figure 03_image142
IJ-2
Figure 03_image144
IJ-3
Figure 03_image146
IJ-4
Figure 03_image148
IK-1
Figure 03_image150
IK-2
Figure 03_image152
IK-3
Figure 03_image154
IK-4
Figure 03_image156
IL-1
Figure 03_image158
IL-2
Figure 03_image160
IL-3
Figure 03_image162
IL-4
Figure 03_image164
IM-1
Figure 03_image166
IM-2
Figure 03_image168
IM-3
Figure 03_image170
IM-4
Figure 03_image172
IN-1
Figure 03_image174
IN-2
Figure 03_image176
IN-3
Figure 03_image178
IN-4
Figure 03_image180
Ia-1
Figure 03_image182
Ia-2
Figure 03_image184
Ia-3
Figure 03_image186
Ia-4
Figure 03_image188
Ib-1
Figure 03_image190
Ib-2
Figure 03_image192
Ib-3
Figure 03_image194
Ib-4
Figure 03_image196
Ic-1
Figure 03_image198
Ic-2
Figure 03_image200
Ic-3
Figure 03_image202
Ic-4
Figure 03_image204
Id-1
Figure 03_image206
Id-2
Figure 03_image208
Id-3
Figure 03_image210
Id-4
Figure 03_image212
Ie-1
Figure 03_image214
Ie-2
Figure 03_image216
Ie-3
Figure 03_image218
Ie-4
Figure 03_image220
If-1
Figure 03_image222
If-2
Figure 03_image224
If-3
Figure 03_image226
If-4
Figure 03_image228
Ig-1
Figure 03_image230
Ig-2
Figure 03_image232
Ig-3
Figure 03_image234
Ig-4
Figure 03_image236
Ih-1
Figure 03_image238
Ih-2
Figure 03_image240
Ih-3
Figure 03_image242
Ih-4
Figure 03_image244
II-1
Figure 03_image246
II-2
Figure 03_image248
II-3
Figure 03_image250
II-4
Figure 03_image252
Ij-1
Figure 03_image254
Ij-2
Figure 03_image256
Ij-3
Figure 03_image258
Ij-4
Figure 03_image260
Ik-1
Figure 03_image262
Ik-2
Figure 03_image264
Ik-3
Figure 03_image266
Ik-4
Figure 03_image268
Il-1
Figure 03_image270
Il-2
Figure 03_image272
Il-3
Figure 03_image274
Il-4
Figure 03_image276
Im-1
Figure 03_image278
Im-2
Figure 03_image280
Im-3
Figure 03_image282
Im-4
Figure 03_image284
In-1
Figure 03_image286
In-2
Figure 03_image288
In-3
Figure 03_image290
In-4.
一種液晶組合物,其含有請求項1至6中任一項所述的具有負介電各向異性的液晶化合物,所述的具有負介電各向異性的液晶化合物按照重量百分含量計算為20%以下,含有多種所述的負介電各向異性的液晶化合物時,所述的負介電各向異性的液晶化合物的含量的總和以重量百分含量計算為50%以下。 A liquid crystal composition, which contains the liquid crystal compound with negative dielectric anisotropy described in any one of claims 1 to 6, and the liquid crystal compound with negative dielectric anisotropy is calculated as 20% or less. When multiple liquid crystal compounds with negative dielectric anisotropy are contained, the sum of the contents of the liquid crystal compounds with negative dielectric anisotropy is 50% or less by weight percentage. 一種液晶顯示器件,其包含請求項1至6中任一項所述的具有負介電各向異性的液晶化合物,或者包含請求項7所述的液晶組合物,所述液晶顯示器件為有源矩陣顯示器件,或無源矩陣顯示器件。 A liquid crystal display device, which comprises the liquid crystal compound with negative dielectric anisotropy described in any one of claim items 1 to 6, or comprises the liquid crystal composition described in claim item 7, and the liquid crystal display device is an active Matrix display devices, or passive matrix display devices.
TW111121360A 2021-08-17 2022-06-09 Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition, liquid crystal display device TWI797021B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110945037.1 2021-08-17
CN202110945037.1A CN113512427B (en) 2021-08-17 2021-08-17 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device

Publications (2)

Publication Number Publication Date
TW202309252A TW202309252A (en) 2023-03-01
TWI797021B true TWI797021B (en) 2023-03-21

Family

ID=78068212

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111121360A TWI797021B (en) 2021-08-17 2022-06-09 Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition, liquid crystal display device

Country Status (2)

Country Link
CN (1) CN113512427B (en)
TW (1) TWI797021B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114381279B (en) * 2022-01-17 2024-01-30 烟台显华科技集团股份有限公司 Polymerizable compound, composition, and liquid crystal display device

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101120002A (en) * 2005-02-17 2008-02-06 惠氏公司 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
JP2012080063A (en) * 2010-09-08 2012-04-19 Fujifilm Corp Organic electroluminescent element and compound
WO2012142256A2 (en) * 2011-04-12 2012-10-18 The Regents Of The University Of California Modulators of mitochondrial protein import
US10227320B2 (en) * 2015-05-06 2019-03-12 University Of Maryland, College Park Compounds for treating parasitic infections
CN109608423A (en) * 2019-01-18 2019-04-12 重庆医科大学 Using α-phenoxy group ketone as the method for Material synthesis benzofuran derivatives
CN109943346A (en) * 2019-03-05 2019-06-28 曹亚宁 Compound, liquid crystal media, liquid crystal display device and electronic equipment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE481396T1 (en) * 2006-04-25 2010-10-15 Merck Patent Gmbh HEXAHYDRO-DIBENZOFURAN DERIVATIVES
CN107903915A (en) * 2017-12-07 2018-04-13 西安近代化学研究所 A kind of negative liquid crystal compound with benzofuran ring and combinations thereof
KR20200111577A (en) * 2019-03-19 2020-09-29 삼성전자주식회사 Condensed cyclic compound and organic light emitting device comprising the same
CN113234045B (en) * 2021-06-17 2023-05-02 烟台显华科技集团股份有限公司 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101120002A (en) * 2005-02-17 2008-02-06 惠氏公司 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
JP2012080063A (en) * 2010-09-08 2012-04-19 Fujifilm Corp Organic electroluminescent element and compound
WO2012142256A2 (en) * 2011-04-12 2012-10-18 The Regents Of The University Of California Modulators of mitochondrial protein import
US10227320B2 (en) * 2015-05-06 2019-03-12 University Of Maryland, College Park Compounds for treating parasitic infections
CN109608423A (en) * 2019-01-18 2019-04-12 重庆医科大学 Using α-phenoxy group ketone as the method for Material synthesis benzofuran derivatives
CN109943346A (en) * 2019-03-05 2019-06-28 曹亚宁 Compound, liquid crystal media, liquid crystal display device and electronic equipment

Also Published As

Publication number Publication date
TW202309252A (en) 2023-03-01
CN113512427A (en) 2021-10-19
CN113512427B (en) 2023-04-28

Similar Documents

Publication Publication Date Title
TWI798860B (en) Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition, liquid crystal display device
US9540565B2 (en) Liquid crystal compounds containing dibenzopyran derivatives of naphthenic base and application thereof
US9969935B2 (en) Liquid crystal composition and liquid crystal display device
JP5382268B1 (en) Compound with 2-fluorophenyloxymethane structure
CN107207965B (en) Nematic liquid crystal composition and liquid crystal display element using same
TW201348412A (en) Compound having four polymerizable groups, liquid crystal composition and liquid crystal display device
KR20140043838A (en) Liquid crystal composition and liquid crystal display device comprising the liquid crystal composition
JP5435318B1 (en) Compound with 2-fluorophenyloxymethane structure
TWI797021B (en) Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition, liquid crystal display device
KR20200084327A (en) Polymerizable compound, liquid crystal composition and liquid crystal display device using same
TW202305096A (en) Liquid crystal compound with negative dielectric anisotropy, liquid crystal composition and liquid crystal display device
JP6070110B2 (en) Compound with fluorinated naphthalene structure
JP5614003B2 (en) Difluorobenzene derivative, liquid crystal composition containing the compound, and liquid crystal display device
EP0729498B1 (en) Chiral nematic liquid crystalline compositions
TW200528540A (en) A liquid crystalline compound for vertical alignment and a liquid crystalline composition comprising the same
KR20090117971A (en) 1-(trifluoromethyl)naphthalene derivative
CN109181712B (en) Benzofuran liquid crystal compound with difluoromethyl ether bridge bond and composition thereof
US5378393A (en) Glassy chiral nematic liquid crystalline compositions of low molar mass and optical devices formed from same
TW201702360A (en) Liquid crystal compound and liquid crystal composition comprising the same
CN113354607A (en) Negative liquid crystal compound, liquid crystal composition, liquid crystal display element and liquid crystal display
US6558572B2 (en) Glass-forming liquid crystalline compositions and optical devices formed therefrom
WO2021192439A1 (en) Liquid crystal composition, liquid crystal display element and compound
TW201904953A (en) 2,3-dihydrobenzothiophene derivative
KR20240034138A (en) Liquid crystal composition and liquid crystal display device
TW202134412A (en) Polymerizable compound, liquid crystal composition, and liquid crystal display device